US9074302B2 - Methods of making drawn silk fibers - Google Patents

Methods of making drawn silk fibers Download PDF

Info

Publication number
US9074302B2
US9074302B2 US13/498,722 US201013498722A US9074302B2 US 9074302 B2 US9074302 B2 US 9074302B2 US 201013498722 A US201013498722 A US 201013498722A US 9074302 B2 US9074302 B2 US 9074302B2
Authority
US
United States
Prior art keywords
silk
fiber
fibers
egel
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13/498,722
Other versions
US20120244143A1 (en
Inventor
Tim Jia-Ching Lo
Gary G. Leisk
David L. Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts University
Original Assignee
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts University filed Critical Tufts University
Priority to US13/498,722 priority Critical patent/US9074302B2/en
Assigned to TRUSTEES OF TUFTS COLLEGE reassignment TRUSTEES OF TUFTS COLLEGE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAPLAN, DAVID L., LEISK, GARY G., LO, TIM JIA-CHING
Assigned to TRUSTEES OF TUFTS COLLEGE reassignment TRUSTEES OF TUFTS COLLEGE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAPLAN, DAVID L., LEISK, GARY G., LO, TIM JIA-CHING
Publication of US20120244143A1 publication Critical patent/US20120244143A1/en
Application granted granted Critical
Publication of US9074302B2 publication Critical patent/US9074302B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F4/00Monocomponent artificial filaments or the like of proteins; Manufacture thereof
    • D01F4/02Monocomponent artificial filaments or the like of proteins; Manufacture thereof from fibroin
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D1/00Treatment of filament-forming or like material
    • D01D1/02Preparation of spinning solutions
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/02Optical fibres with cladding with or without a coating
    • G02B6/02033Core or cladding made from organic material, e.g. polymeric material

Definitions

  • This invention provides for compositions and methods for drawing egel silk fibroin fibers.
  • the resulting fibers can transmit light and hence can be used as optical fiber.
  • the silk fiber of the invention can be used in materials such as textile, medical sutures, and tissue materials, as well as conferring optical properties into these materials.
  • Optical fibers are typically flexible glass rods as thin as hair, which act as “wires” transmitting light or other data. In simple terms, they work by totally reflecting the light inside so that none of it leaks out.
  • Synthetic polymer optical fibers are typically formed by extruding a viscous liquid through a small orifice called a spinneret. The viscous liquid is turned into a continuous filament which can be further solidified using post-extrusion processing.
  • Fiber optics has made important contributions to the medical field, especially with regards to surgery. This has been accomplished by cutting and polishing the ends of a very slim bundle of fibers, to form a fiberscope. The light is sent to the site of inquiry, reflected off of the area that the doctor wishes to see, and sent back to a receiver. Afterwards, the image is magnified to be analyzed. Because optical fibers are so flexible, they are able to navigate around the curvy parts of the human body in areas such as the stomach, heart, blood vessels, and joints. It is now even becoming possible to do surgery with instruments attached to the optical fibers, such as joint surgeries. Fiber optics is becoming especially important in heart surgery, since it can be done without disturbing the functions of this delicate organ.
  • a desirable alternative to glass or synthetic fibers would be a natural polymer fiber that is biodegradable, biocompatible, made by relatively simple techniques from renewable sources and aqueous procedures, can transmit light, and can also be weaved as conventional fibers into textiles, medical sutures, implantable tissue materials and in the mean time conferring optical properties to these materials.
  • Silk electrogelation is a processing modality for silk fibroin protein.
  • the egel process applies an electric field to solubilized silk fibroin solution, causing a transformation of the silk solution's random coil conformation into a meta-stable, silk I conformation.
  • the resulting gel-like substance has many interesting properties, including muco-adhesive qualities and the ability to be further transformed into other conformations, including back to a random coil conformation or to an even higher-order ⁇ -sheet conformation.
  • the silk fibers in accordance with the present invention may be manufactured without the need for high-temperature furnaces and the large expense of conventional systems.
  • a silk fiber in accordance with the present invention uses a silk fibroin gel as a base material to create fibers with improved mechanical properties, such as, for example, shear strength.
  • silk fibers in accordance with the present invention are biocompatible, biodegradable and implantable.
  • the silk fiber produced with the method of the invention is transparent and can transmit light, and thus can be used as an optical fiber. Accordingly, the silk fibers may be used to monitor health conditions in vivo or may be implanted as a part of a sensing system to monitor and transmit information related to disease processes, treatment efficacy, and tissue growth.
  • the silk fibroin gel in accordance with the present invention may be used as a coating for any number of optical fiber and transmission media devices.
  • silk fibers of the invention can be incorporated in textile-based components or structures, such as mats, yarns, and braids, to provide the smart-structure or smart-material enhancement of carrying sensor or computational data through the structure, due to the light transmission properties of the silk fiber.
  • One such application could be a soft robot body containing silk optical fiber, in which sensor data is transmitted through the body wall, without the need for traditional wiring.
  • Silk optical fibers can be used as sensors, such as in the measurement of curvature in biomechanical applications (such as a spine) or in measuring structure and building deformation (such as bridges or buildings in normal or severe weather or under unusual loading, such as in an earthquake).
  • the methods of producing silk egel fibers include an electrogelation process such as: applying an electric field (e.g., 25 VDC) to platinum electrodes submerged in solubilized silk solution. After a suitable time of electric field application (e.g., 10 minutes), a gel-like material has formed on the positive electrode, which has an increased level of meta-stable silk I conformation. When this silk gel is placed into a heated water bath, the gel dissociates into a fairly viscous liquid that settles at the bottom of the water bath. This viscous fluid can then be drawn out of the water bath to form a long fiber with unique mechanical properties and adjustable cross-section.
  • an electric field e.g. 25 VDC
  • the drawn fibers may be tougher if the dissociated gel is quenched in sub-zero temperature water (water which contains salt and crushed ice) before drawing into room-temperature air environment.
  • sub-zero temperature water water which contains salt and crushed ice
  • the behavior of the fibers in a humid environment is consistent with the elongation/contraction response that is reported in spider silks.
  • the drawn egel fiber transmits light.
  • Silk egel fiber drawing creates silk fibers with robust mechanical properties. Given the ability to artificially create fibers with customized properties and size provides for many applications. For example, all-silk composite materials can be constructed from silk fibroin solutions, eliminating the need for traditional spooled silk fibers.
  • the drawn silk fibers exhibit supercontraction when fully hydrated. Furthermore, the fibers exhibit reversible stretching and contraction under humidity cycling. Accordingly, silk fibers may be useful as an analog to muscle fibers to make artificial muscles, actuators for small and/or biomimetic robots, or for other applications such as drug release.
  • the drawn fibers transmit light
  • the fiber can be used in vivo to monitor health conditions, implanted as part of a sensing system to monitor healing, or incorporated in tissue engineering constructs to relay information on tissue ingrowth and scaffold degradation.
  • silk fibers can be used for long-range or short-range communication, in illumination, or laser-based applications. Because silk is biodegradable, the optical fiber would eventually degrade and absorb into the body.
  • a method of creating a silk fiber comprising: applying an electric field to a solubilized silk fibroin solution to create a silk fibroin gel; quenching the silk fibroin gel in water to generate a viscous silk liquid; and drawing the silk fibroin gel from the viscous silk liquid to create a silk fiber.
  • the water has a temperature at or below 0° C. In another embodiment, the water has a temperature in the range from 40° C. to 80° C., inclusive.
  • the drawing of the silk is performed at a temperature within the range of 10° C. to 40° C., inclusive.
  • the method further comprises drying the silk fiber.
  • the method further comprises contracting the silk fiber.
  • contracting the silk fiber includes reducing the ambient humidity to which the silk fiber is exposed.
  • the method further comprises expanding the silk fiber.
  • expanding the silk fiber includes increasing the ambient humidity to which the silk fiber is exposed.
  • the silk fiber is processed with a methanol treatment to generate a water-insoluble silk fiber.
  • the method further comprises wrapping a plurality of silk optical fibers.
  • the silk fiber is an optical fiber.
  • the method further comprises forming a fiber optic cable with the silk optical fiber.
  • the method further comprises receiving, by the silk optical fiber, incident light from a light source.
  • the silk optical fiber is a waveguide.
  • the silk optical fiber is a single mode fiber. In another embodiment, the silk optical fiber is a multi-mode fiber.
  • FIGS. 1A-1D show a series of photographs presenting a time lapse sequence showing effects of submerging electrogelated silk (egel) in 60° C.-75° C. water: ( 1 A) 5 seconds; ( 1 B) 15 second; ( 1 C) 25 seconds; and ( 1 D) 35seconds.
  • FIG. 2 is a photograph showing formation of silk egel “structures” in 60° C.-75° C. water.
  • FIGS. 3A-3D show a series of time lapse photographs showing fiber drawing of egel from a 60° C.-70° C. water bath.
  • FIGS. 4A-4C show silk egel ( 4 A) before heating; ( 4 B) with heat gun; and ( 4 C) after heating to about 60° C.
  • FIGS. 5A-5C show silk egel: ( 5 A) before heating; ( 5 B) in water bath to cool down; and ( 5 C) after extrusion from syringe.
  • FIGS. 6A-6B show heated silk egel quenched in an ice bath: ( 6 A) after initial quenching; and ( 6 B) after about 1 minute.
  • FIGS. 7A-7B depict a custom fixture for exploration of light carrying capability of drawn silk egel fiber: ( 7 A) overall setup; and ( 7 B) zoomed image of fiber holder.
  • FIGS. 8A-8B presents images that demonstrate the ability for the drawn silk egel fibers to transmit light: ( 8 A) light projects from the end of the drawn silk egel fiber; and ( 8 B) bent fiber is glowing with light.
  • FIGS. 9A-9C show images of ( 9 A) initial egel formation; ( 9 B) after 5 minutes of electrogelation; and ( 9 C) overview of power supply, egel tube setup, IR thermometer for recording temperature, and hot plate.
  • FIGS. 10A-10C depicts egel silk fiber drawing from a ice water bath: ( 10 A) quenching of heated egel into an ice bath; ( 10 B) a egel silk fiber immediately after being drawn from the bath (using an insulated wire); and ( 10 C) a drawn egel silk fiber after some drying in air.
  • FIG. 11 is a stereo microscope image of a typical egel silk fiber drawn from an ice water bath and dried in ambient air. The diameter between the bifurcations is approximately 100 ⁇ m.
  • FIG. 12 shows time-lapse photographs of egel silk fibroin submerged in about 60° C. water. Over about a 5 minute period, the silk structure in the gel appears to separate from the water content, falling into a pool at the base of the beaker.
  • FIGS. 13A-13E show egel silk fiber drawn from a heated bath: ( 13 A- 13 B) insulated wire dragging through silk pool; ( 13 C- 13 D) fiber drawn rapidly from the bath.
  • FIGS. 14A-14E are time-lapse photographs of a weighted drawn silk egel fiber: ( 14 A) fiber at ambient humidity with 133 mg weight attached; and ( 14 B- 14 E) elongation of fiber after 20 seconds of exposure to steam.
  • FIG. 15 shows an example humidity chamber showing the Kaz Ultrasonic Humidifier (right), Lufft humidity/temperature device (center), and drawn egel fiber hanging next to a metric scale (left).
  • FIG. 16A-16C depicts drawn silk egel fiber exposed to dry humidity: ( 16 A) initial fiber length of about 15 cm with 33 mg weight attached at ambient humidity of 44.5%; ( 16 B) at 94.6% humidity; and ( 16 C) after evacuation to 47.8% humidity.
  • FIGS. 17A-17B exhibits the change in drawn silk egel fiber length: ( 17 A) from 81.7% humidity to ( 17 B) 94.6% humidity.
  • FIGS. 18A-18D represents a comparison of drawn egel silk fiber contraction at relative humidity levels: ( 18 A) 99.7%; ( 18 B) 86.3%; ( 18 C) 71.8%; and ( 18 D) 62.4%.
  • FIG. 19 shows cardboard-mounted fibers positioned in Instron pneumatic grips for tensile tests.
  • FIG. 20 is a graph showing a comparison of load-extension response between several drawn silk egel fibers.
  • FIG. 21A-21B is a stereo microscope and images of three drawn egel fibers produced under unique conditions (1 mm scale bar).
  • FIGS. 22A-22B shows scanning electron microscope (SEM) images of a drawn egel fiber: ( 22 A) at 1560 ⁇ ; and ( 22 B) 1960 ⁇ magnification.
  • Synthetic polymer fibers are typically formed by extruding a viscous liquid through a small orifice called a spinneret.
  • the viscous liquid is turned into a continuous filament which can be further solidified using post-extrusion processing.
  • Four spinning methods are prevalent, including wet, dry, melt, and gel spinning.
  • Wet spinning is used on materials that are dissolved in a solvent.
  • the filaments are drawn through a spinneret that is submerged in a chemical bath that acts as a precipitating liquid. Dry spinning is also employed on materials in solution.
  • solidification occurs as the solvent is driven off by gas (e.g., air)-driven evaporation.
  • Melt spinning involves the extrusion of melted material through a spinneret and solidification by cooling.
  • Optical fibers are transmission media that carry an optical signal from a light source to, for example, an optical receiver of that signal.
  • Optical fibers and fiber optic cables may be used to transmit signals such as voice, video, and data signals.
  • the data signal from a communication signal source such as a telephone or data modem is modulated onto a light wave and transported via the optical fibers to the optical receiver.
  • the data signal is then recovered at the receiver using a demodulation process.
  • Fiber optic cables and their optical fibers have inherent signal attenuation characteristics. Signals transmitted via an optical fiber are attenuated as they travel, and at some distance from the light source the signals reach a sufficiently low level as to require amplification.
  • Conventional glass optical fibers are typically made by either a crucible method, where powdered silica is melted, or by a vapor deposition process.
  • Crucible methods may be used to produce large diameter multimode fibers suitable for short-distance transmission of many light wave signals.
  • Vapor deposition processes are used to create a solid cylinder of core and cladding material that is then heated and drawn into a thinner optical fibers for longer distance communication.
  • Silk electrogelation is a processing modality for silk fibroin protein.
  • the egel process applies an electric field (either direct or alternating current, referred to as DC or AC) to solubilized silk fibroin solution, causing a transformation of the silk protein's random coil conformation into a meta-stable, silk I conformation.
  • the electric field can be applied through using a voltage source, such as a DC or AC voltage source.
  • Direct current is produced by sources such as batteries, thermocouples, solar cells, etc.
  • alternating current (AC) the general powder source for business and residence, may also be used to induce the electrogelation process, although the gel formation may not be as fast as the gelation process induced by direct current voltage.
  • the resulting gel-like substance has a very sticky, thick, mucus-like consistency and has many interesting properties, including muco-adhesive qualities and the ability to be further transformed into other conformations, including back to a random coil conformation or to an even higher-order ⁇ -sheet conformation.
  • the method of eletrogelation, the related parameters used in the eletrogelation process and the structural transition of silk fibroin during the electrogelation process may be found in WO/2010/036992, Active silk muco-adhesives, silk electrogelation process, and devices, which is incorporated herein as a reference in its entirety.
  • silk fibroin includes silkworm fibroin and other insect or spider silk protein (Lucas et al., 13 Adv. Protein Chem. 107-242 (1958)).
  • Silk fibroin can be obtained from a solution containing a dissolved silkworm silk or spider silk.
  • the silkworm silk fibroins are obtained, for example, from the cocoon of Bombyx mori
  • the spider silk fibroins are obtained, for example, from Nephila clavipes .
  • the silk fibroins suitable for use in the present invention can be obtained from a solution containing a genetically engineered silk harvested from bacteria, yeast, mammalian cells, transgenic animals or transgenic plants. See, e.g., WO 97/08315 and U.S. Pat. No. 5,245, 012.
  • An aqueous silk fibroin solution may be prepared from the silkworm cocoons using techniques known in the art. Suitable processes for preparing silk fibroin solution are disclosed in, for example, U.S. patent application Ser. No. 11/247,358, WO/2005/012606, and WO/2008/127401.
  • the concentration of silk fibroin aqueous solution may by decreased by dilution, or increased by dialyzing a lower concentration silk fibroin solution against a hygroscopic polymer, for example, PEG, a polyethylene oxide, amylose or sericin. See, e.g., WO 2005/012606.
  • the resulting silk solution may be further processed, e.g., through centrifugation or micro-filtration, to remove remaining particulates and to reach to a silk fibroin solution with minimal contaminants and reduced scattering for optical applications.
  • the embodiments described herein provide for a silk egel fiber drawing process.
  • the several Examples describe experiments conducted to provide alternative fabrication strategies for silk egel fiber drawing.
  • the results of these experiments show the potential for creating fibers with a range of cross-sections and potentially impressive mechanical properties.
  • the process is aqueous-based and easily set up and executed on a lab bench.
  • the fibers generated can be long, and the process can be both continuous and automated. It appears that a wide range of diameters can be produced.
  • the solubility of the dried fiber can be changed by a post-processing treatment to generate water-insoluble conformations.
  • an alcohol treatment e.g., methanol treatment
  • water annealing treatment of the silk fibers which can be included as part of a continuous processing approach, can provide water-insoluble silk fibers.
  • the ability to drive the fiber diameters to very small cross sections could impart strength through the alignment of molecular chains along the fiber axis.
  • an underwater spinneret may contribute to this strengthening effect.
  • the use of the egel is key in generating fibers that rival the mechanical performance of native silkworm silk fiber.
  • the silk conformation achieved with electrogelation may match the precursor gel-phase present in the glands of living silkworms and spiders before being extruded through spinnerets.
  • This process of fiber drawing may mimic the native process, leading to superior outcomes to all other fiber formation processes using regenerated silk. See, e.g., Zhou et al., Silk Fibers Extruded Artificially from Aqueous Solutions of Regenerated Bombyx mori Silk Fibroin are Tougher than their Natural Counterparts, 21 Adv. Mats. 366-70 (2009). Indeed, the drawn egel silk fibers can be very strong—the smallest-diameter fibers made by the techniques taught herein show higher strength than cocoon fiber.
  • the silk fiber made by the method of the present invention is quite transparent, can transmit light, such as a laser light, and therefore can be used as optical fiber.
  • the embodiments of the present invention thus provide for a method of forming an silk fiber comprising applying an electric field to a solubilized silk fibroin solution, transforming the solubilized silk fibroin solution to a silk gel based upon the applied electric field, converting the silk fibroin gel to a viscous silk liquid (e.g., quenching the silk gel water to generate a viscous silk liquid), and drawing the silk liquid to form a silk fiber.
  • the silk fibroin gel may be heated prior to the quenching step, and the silk fibroin gel may be heated to a temperature higher than the temperature of water used in the quenching step.
  • the silk fibroin gel may be heated to about 60° C., and quenched in a cool water bath (temperature of the water bath is lower than 60° C., such as ⁇ 0° C.).
  • the drawing may be done in water having a temperature at or below 0° C.; in the range from 40° C. to 80° C.; or within the range of 10° C. to 40° C.
  • the method may further include drying the silk fiber.
  • the dried silk fiber is quite transparent and exhibits transmission of laser light.
  • the silk fiber may also be contracted, such as by reducing the ambient humidity to which the silk fiber is exposed; or expanded, such as by increasing the ambient humidity to which the silk fiber is exposed. Additionally, the silk fiber may be further processed, for example with a methanol treatment, to generate water-insoluble silk fiber.
  • the silk fiber is used as optical fiber.
  • the method may also further include forming a fiber optic cable with a silk optical fiber or a plurality of silk optical fibers.
  • the silk optical fiber of the present invention may receive incident light from a light source; and may act as a waveguide, a multimode fiber, or a single mode fiber.
  • a plurality of silk optical fibers may be wrapped into a fiber optic cable by techniques well-known in the art.
  • Silk fibers produced from the method of the invention may be wrapped with other type of fibers made from silk or other materials, natural or synthetic, into a fiber bundle or fiber composite.
  • a fiber composite may be made from one or more silk fibers of the invention combined with one or more native silkworm fibroin fibers to form a silk-fiber-based matrix.
  • Immunogenic components in the silk (such as sericin) may be removed from native silk fiber if such silk fiber based matrix is to be used as implantable materials.
  • These silk fiber based matrix may be used to produce tissue materials for surgical implantation into a compatible recipient, e.g., for replacement or repair of damaged tissue.
  • tissue materials that can be produced include ligaments or tendons such as anterior cruciate ligament, posterior cruciate ligament, rotator cuff tendons, medial collateral ligament of the elbow and knee, flexor tendons of the hand, lateral ligaments of the ankle and tendons and ligaments of the jaw or temporomandibular joint; cartilage (both articular and meniscal), bone, muscle, skin and blood vessels.
  • ligaments or tendons such as anterior cruciate ligament, posterior cruciate ligament, rotator cuff tendons, medial collateral ligament of the elbow and knee, flexor tendons of the hand, lateral ligaments of the ankle and tendons and ligaments of the jaw or temporomandibular joint
  • cartilage both articular and meniscal
  • Methods of making tissue materials or medical device using silk-fiber based matrix or silk composite containing silk fibers may be found in, e.g., U.S. Pat. No. 6,902,932, Helically organized silk fibroin fiber bundles for matrices in
  • Silk fibers produced from the method of the invention may be incorporated into textile (e.g., yarns, fabrics) and textile-based structures using traditional textile-processing equipment, including winding, twisting, flat braiding,weaving, spreading, crocheting, bonding, tubular braiding, knitting, knotting, and felting (i.e., matting, condensing or pressing) machines.
  • textiles e.g., yarns, fabrics
  • textile-based structures using traditional textile-processing equipment, including winding, twisting, flat braiding,weaving, spreading, crocheting, bonding, tubular braiding, knitting, knotting, and felting (i.e., matting, condensing or pressing) machines.
  • Such textiles can be incorporated in composite materials and structures through many known composite-manufacturing processes.
  • Silk fibers produced from the method of the invention may be combined with other forms of silk material, such as silk films (WO2007/016524), coatings (WO2005/000483; WO2005/123114), microspheres (PCT/US2007/020789), layers, hydrogel (WO2005/012606; PCT/US08/65076), mats, meshes, sponges (WO2004/062697), 3-D solid blocks (WO2003/056297), etc., to form an all-silk composite.
  • the silk composite material can be reinforced by silk fiber, as well as incorporate the optical property of silk optical fiber into the composite.
  • a one, two or three-dimensional silk composite may be prepared by exposing silk fiber with silk fibroin solution and drying or solidifying the silk fibroin solution containing the silk fiber of the invention to form the silk composite.
  • Different solidifying processes and additional approaches for processing silk fibroin solution into different formats of silk materials can be used. See, e.g., WO/2005/012606; WO/2008/150861; WO/2006/042287; WO/2007/016524; WO 03/004254, WO 03/022319; WO 04/000915.
  • silk fiber produced by the method of the invention can be combined with one or more other natural or synthetic biocompatible or non-biocompatible polymers, and incorporated into a composite with different material formats, such as fibers, films, coatings, layers, gels, mats, meshes, hydrogel, sponges, 3-D scaffold, and the like.
  • the non-limiting biocompatible polymers include polyethylene oxide, polyethylene glycol, collagens (native, reprocessed or genetically engineered versions), polysaccharides (native, reprocessed or genetically engineered versions, e.g.
  • hyaluronic acid alginates, xanthans, pectin, chitosan, chitin, and the like
  • elastin native, reprocessed or genetically engineered and chemical versions
  • agarose polyhydroxyalkanoates
  • pullan starch (amylose amylopectin)
  • cellulose cotton, gelatin, fibronectin, keratin, polyaspartic acid, polylysin, alginate, chitosan, chitin, poly lactide, poly glycolic, poly(lactide-co-glycolide), poly caproloactone, polyamides, polyanhydrides, polyaminoacids, polyortho esters, poly acetals, proteins, degradable polyurethanes, polysaccharides, polycyanoacrylates, glycosamino glycans (e.g., chrondroitin sulfate, heparin, etc.), and the like.
  • non-biodegradable polymers include polyamide, polyester, polystyrene, polypropylene, polyacrylate, polyvinyl, polycarbonate, polytetrafluorethylene and nitrocellulose material.
  • silk fiber When incorporating silk fiber into the composite, one or more of these aforementioned polymers can be combined. See also, e.g., U.S. Pat. No. 6,902,932; U.S. Patent Application Publication Nos. 2004/0224406; 2005/0089552; 2010/0209405.
  • composite materials containing the silk fiber of the invention can be tailored to specific applications.
  • single fiber layers have been shown to be very tough and flexible.
  • Cylindrical mandrels can be used to produce very stiff rod or tubular constructs that can have impressive compressive, tensile, flexural, and torsional properties. Custom wavy or highly curved geometries can also be produced.
  • the composite material generally enhances the matrix properties such as mechanical strength, porosity, degradability, and the like, and also enhances cell seeding, proliferation, differentiation or tissue development when used as medical suture or implantable tissue materials.
  • Silk fibroin in the silk fiber can also be chemically modified with active agents in the solution, for example through diazonium or carbodiimide coupling reactions, avidin-biodin interaction, or gene modification and the like, to alter the physical properties and functionalities of the silk protein. See, e.g., PCT/US09/64673; PCT/US10/42502; PCT/US2010/41615; U.S. patent application Ser. No. 12/192,588.
  • Silk fiber of the invention may include at least one active agent.
  • the agent may be embedded in the fiber or immobilized on the surface of the fiber.
  • the active agent may be a therapeutic agent or biological material, such as chemicals, cells (including stem cells) or tissues, proteins, peptides, nucleic acids (e.g., DNA, RNA, siRNA), nucleic acid analogues, nucleotides, oligonucleotides or sequences, peptide nucleic acids(PNA), aptamers, antibodies or fragments or portions thereof (e.g., paratopes or complementarity-determining regions), antigens or epitopes, hormones, hormone antagonists, cell attachment mediators (such as RGD), growth factors or recombinant growth factors and fragments and variants thereof, cytokines, enzymes, antioxidants, antibiotics or antimicrobial compounds, anti-inflammation agents, antifungals, viruses, antivirals, toxins, prodrugs, drugs, dyes, amino acids, vitamins, chem
  • antibiotics suitable for use herein include, but are not limited to, aminoglycosides (e.g., neomycin), ansamycins, carbacephem, carbapenems, cephalosporins (e.g., cefazolin, cefaclor, cefditoren, cefditoren, ceftobiprole), glycopeptides (e.g., vancomycin), macrolides (e.g., erythromycin, azithromycin), monobactams, penicillins (e.g., amoxicillin, ampicillin, cloxacillin, dicloxacillin, flucloxacillin), polypeptides (e.g., bacitracin, polymyxin B), quinolones (e.g., ciprofloxacin, enoxacin, gatifloxacin, ofloxacin, etc.), sulfonamides (e.g., sulfasal
  • Exemplary cells suitable for use herein may include, but are not limited to, progenitor cells or stem cells (e.g., bone marrow stromal cells), ligament cells, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, epithelial cells, endothelial cells, urothelial cells, fibroblasts, myoblasts, chondrocytes, chondroblasts, osteoblasts, osteoclasts, keratinocytes, hepatocytes, bile duct cells, pancreatic islet cells, thyroid, parathyroid, adrenal, hypothalamic, pituitary, ovarian, testicular, salivary gland cells, adipocytes, and precursor cells.
  • progenitor cells or stem cells e.g., bone marrow stromal cells
  • ligament cells smooth muscle cells
  • skeletal muscle cells skeletal muscle cells
  • cardiac muscle cells epithelial cells
  • endothelial cells urothelial cells
  • fibroblasts myoblasts
  • Exemplary antibodies include, but are not limited to, abciximab, adalimumab, alemtuzumab, basiliximab, bevacizumab, cetuximab, certolizumab pegol, daclizumab, eculizumab, efalizumab, gemtuzumab, ibritumomab tiuxetan, infliximab, muromonab-CD3, natalizumab, ofatumumab omalizumab, palivizumab, panitumumab, ranibizumab, rituximab, tositumomab, trastuzumab, altumomab pentetate, arcitumomab, atlizumab, bectumomab, belimumab, besilesomab, biciromab, canakinumab, capromab pende
  • Exemplary enzymes suitable for use herein include, but are not limited to, peroxidase, lipase, amylose, organophosphate dehydrogenase, ligases, restriction endonucleases, ribonucleases, DNA polymerases, glucose oxidase, laccase, and the like.
  • Additional active agents to be used herein include cell growth media, such as Dulbecco's Modified Eagle Medium, fetal bovine serum, non-essential amino acids and antibiotics; growth and morphogenic factors such as fibroblast growth factor, transforming growth factors, vascular endothelial growth factor, epidermal growth factor, platelet derived growth factor, insulin-like growth factors), bone morphogenetic growth factors, bone morphogenetic-like proteins, transforming growth factors, nerve growth factors, and related proteins (growth factors are known in the art, see, e.g., Rosen & Thies, C ELLULAR & M OLECULAR B ASIS B ONE F ORMATION & R EPAIR (R.G.
  • cell growth media such as Dulbecco's Modified Eagle Medium, fetal bovine serum, non-essential amino acids and antibiotics
  • growth and morphogenic factors such as fibroblast growth factor, transforming growth factors, vascular endothelial growth factor, epidermal growth factor, platelet derived growth factor
  • anti-angiogenic proteins such as endostatin, and other naturally derived or genetically engineered proteins
  • polysaccharides, glycoproteins, or lipoproteins such as antibiotics and antiviral agents, chemotherapeutic agents (i.e., anticancer agents), anti-rejection agents, analgesics and analgesic combinations, anti-inflammatory agents, and steroids.
  • the active agent may also be an organism such as a bacterium, fungus, plant or animal, or a virus.
  • the active agent may include neurotransmitters, hormones, intracellular signal transduction agents, pharmaceutically active agents, toxic agents, agricultural chemicals, chemical toxins, biological toxins, microbes, and animal cells such as neurons, liver cells, and immune system cells.
  • the active agents may also include therapeutic compounds, such as pharmacological materials, vitamins, sedatives, hypnotics, prostaglandins and radiopharmaceuticals.
  • Additional applications for silk optical fibers drawn from silk egels include photomechanical actuation, electro-optic fibers, and smart materials.
  • the silk fibers of the present invention When the silk fibers of the present invention is used in the textile, medical suture materials or tissue materials, either separately or combined into a composite, stimulus can be incorporated in the aforementioned method of producing the textile medical suture materials or tissue materials.
  • chemical stimuli, mechanical stimuli, electrical stimuli, or electromagnetic stimuli can also be incorporated herein.
  • the silk fiber contained in the textile, medical suture materials or tissue materials can be used to transmit the optical signals that may be from the stimuli or converted from the stimuli originated from the environment (e.g., tissue, organ or cells when used as implant materials) and influence the properties of the textile, suture or tissue materials.
  • silk optical fiber may be used to transmit the optical signal to the applied medium, such as cells or tissues when used as implant materials, and modulate the activities of the cells or tissues.
  • cell differentiation is known to be influenced by chemical stimuli from the environment, often produced by surrounding cells, such as secreted growth or differentiation factors, cell-cell contact, chemical gradients, and specific pH levels, to name a few. Some stimuli are experienced by more specialized types of tissues (e.g., the electrical stimulation of cardiac muscle). The application of such stimuli that may be directly or indirectly transmitted by optical signal is expected to facilitate cell differentiations.
  • a controlled drug delivery system may be made available by incorporating the silk optical fiber into the system, for example, the drug administration and release can be controlled in a manner that precisely matches physiological needs through the external stimuli applied on the silk optical fiber.
  • the critical angle at which a light ray can enter the first medium and then travel between the two mediums, without crossing into the second medium. If the angle at which the ray passes through the first medium is greater than the critical angle, the ray will experience total internal reflection, where it will just reflect off the surface between the two mediums and reenter the first medium. This is the case with contemporary optical fibers.
  • the silk optical fiber of the present embodiments is well-able to conduct light while bent, as shown in FIG. 8 b .
  • the silk-based optical fibers of the present invention may be used, for example, in systems for endoscopy which combine fiber optics and powerful lenses.
  • the medical device may include objective lenses, rod lenses, ocular lenses, light fibers, light source, camera for imaging.
  • a micro-camera may be attached to the eyepiece and an image viewed on a monitor.
  • the endoscopy system may use charge-coupled devices that capture and store image data. For example, a 2D array of individual elements that can store an electric charge, and can respond to 70% of the incident light.
  • Light sourced include tungsten filament lamp, halogen reflector lamp, rare-earth xenon lamp give high intensity light and true color display (xenon daylight effect).
  • the typical flexible endoscope has a bending radius of about 15 mm and two silk fiber optic cables: one is a light conduit (incoherent), second is used to image transmission (coherent).
  • the image fiber may have an image resolution of approximately 10,000 pixels per square mm.
  • Applications for endoscopy include surgical imaging systems that can simulate the optimal path for the surgeon (e.g., inside the brain for neurosurgery). In laser, brain surgery within the skull, the endoscopic device is threaded like a wire through a one-eighth-inch incision in the skull, implanted in the tumor like a biopsy needle, and turned on for spurts of a few seconds.
  • nonimaging edge-ray concentrators may be well suited to a number of laser fiber optic contact surgical procedures where sizable increases in irradiance are required at maximum collection efficiency, and light must be emitted uniformly over a wide angular range.
  • the delivered irradiance from nonimaging designs can be more than double, at maximum radiative efficiency, while producing a Lambertian absorber, i.e., uniform emission over the entire hemisphere.
  • Additional modifications of the egel drawing process are supported by the disclosure provided herein, including automation, that may improve the generation of controllable and consistent fiber diameters, and may eliminate the bifurcation anomalies. Further optimizing and characterizing silk egel drawing, improving the quality control of the fibers, generating improved light-carrying fibers, and exploring further the hydration-driven contraction and elongation are within the scope of the present invention.
  • the present invention may be as defined in any one of the following numbered paragraphs:
  • Solubilized silk fibroin aqueous stock solutions were prepared as described previously. Sofia et al., 54 J. Biomed. Mater. Res. A 139-48 (2001). Briefly, cocoons of B. mori were boiled for 20 min in an aqueous solution of 0.02 M sodium carbonate, and then rinsed thoroughly with water (ultra-pure water processed via Milli-Q® Water System, Millipore, Billerica, Mass.). After drying, the extracted silk fibroin was dissolved in a 9.3 M LiBr solution at 60° C. for 4 hr, yielding a 20% (w/v) solubilized silk fibroin solution.
  • the resulting solution was dialyzed against distilled water using Slide-A-Lyzer® 3.5K MWCO dialysis cassettes (Pierce, Rockford, Ill.) for three days to remove the residual salt.
  • the solution was optically clear after dialysis and was centrifuged twice at 10,000 rpm for 20 min to remove silk aggregates as well as debris from original cocoons.
  • the final concentration of solubilized silk fibroin aqueous solution was approximately 8% (w/v). This concentration was determined by drying the solution with a known volume and weighing the residual solid. The 8% silk fibroin solution was stored at 4° C. and diluted with water before use.
  • the autoclaved silk solution After a week of storage at 5° C.-10° C., the autoclaved silk solution exhibited some electrogelation response, albeit reduced. As subsequent experiments appeared to suggest, the electrogelation of a heated silk solution may have changed the conformation of the silk solution from random coil to silk I, but that the material was not staying in contact with the positive (typically platinum) electrode.
  • Electrogelated silk was first created in a “standard” setup (8% w/v silk solution, platinum electrodes, and Falcon tube as above). After 10 min of electrogelation, the gel which formed on the positive electrode was transferred to a beaker containing water heated to 60° C.-75° C.
  • FIG. 1 shows images of the gel response at 10 sec time intervals. Upon immersion in the warm water, the egel on the Pt seemed to dissociate and fall to the base of the beaker, apparently due a density differential. Simultaneously, any bubbles trapped in the egel rose to the water surface as they were released. The dissociation process continued until it appeared only ⁇ -sheet material was remaining on the Pt electrode.
  • FIG. 3 shows time lapse photos of a “fiber” being drawn out of the heated bath. The fiber was drawn up at a rate of about 1 inch/second. Initial success led to fiber lengths of between 40 and 50 inches. The fiber lengths could be longer, depending on the amount of silk in the water, the temperature of the water, and the drawing rate.
  • the drawn fibers were very sticky (if two fibers tangled, they would stick together). Over a period of minutes, the fiber would become thinner, less sticky, and more brittle. After between 40 min and 60 min, the fibers could be handled without becoming stuck to other surfaces or itself. Perhaps the solidification is due to a drying effect, where water entrained in the fiber was evaporating. After drying, the fibers had surprising strength, but would quickly become soft when rehydrated in water (especially warm water).
  • thermocouple was used to monitor temperature of the egel and liquid throughout the experiment with National Instruments' CompactDAQ data acquisition hardware and LabVIEW software. This experiment was conducted by performing two complete heating/cooling cycles. A heat gun was used for heating and a water bath for cooling ( FIG. 5 b ).
  • this experiment included the use of a type T thermocouple and National Instruments' CompactDAQ data acquisition hardware and LabVIEW software to monitor bath temperature.
  • Silk egel was placed into a beaker of water heated to 60° C. After the egel would dissociate and sink to the bottom of the water bath, “fibers” of the liquid silk were drawn upward out of the bath. Depending on speed and height above the water bath, the fibers could be drawn to various diameters. After hanging each drawing fiber on a lab bench shelf, the initially sticky and non-uniform fiber would begin to dry/solidify. The fiber also tended to decrease in diameter and become more uniform. The final fibers exhibited impressive tensile properties, but were fairly brittle. If the dry fibers were wrapped into a curvature of less than about 90° C., they tended to fracture. Although the surface of the fiber was more smooth than after initial drawing, there were still noticeable bumps and rough sections on the fiber.
  • an ice bath was created using a beaker of tap water and ice chips. The temperature was measured to be around 0° C.
  • silk egel was first heated to above 60° C. with a heat gun set to medium. The egel was extruded through the needle end of the syringe (no needle attached) into the ice bath.
  • the gel formed a vertical “fiber” that tended to stay suspended in the water, as shown in FIG. 6 a .
  • the appearance of the gel tended to change from fairly transparent to a whitish color, as shown in FIG. 6 b . This was speculated to be due to conversion of the silk I egel conformation to ⁇ -sheet. Future materials characterization will confirm this.
  • the liquid silk “fiber” that had been quenched in the ice bath was then drawn out of the bath.
  • the fiber could be drawn to a fairly long length.
  • the fiber was as sticky as the prior fibers, but more prone to failure during drawing. This fiber appeared to be much more homogeneous, with a fairly smooth surface and consistent cross-sectional geometry.
  • the fiber was found to have become smaller in diameter, but overall was much tougher than the prior fibers: It was not as brittle and could withstand considerable tensile loading. The fiber appeared to be fairly transparent, which provides promise that such fibers could be used to transmit light.
  • Drawn silk egel fibers appear to be fairly transparent, and may be manufactured and used to transmit light.
  • a simple experimental apparatus was built, as shown in FIG. 7 a in which a manual x-y stage was mounted vertically to an aluminum base. A presentation-style laser pointer was held firmly to the stage. A fiber holder was formed using machinable wax. A very small hole was drilled in the wax to snugly hold an egel fiber, as shown in FIG. 7 b .
  • the results of the tests, shown in FIG. 8 a laser light was carried through a fiber and projected onto a surface from the fiber end. The figure shows a second light patch above the fiber, which represents the direct transmission of light through the fiber holder hole.
  • FIG. 8 b demonstrates the ability of a fiber to transmit light around a bend. Adjustments assured that the images are not due to light reflection on the outside of the fibers.
  • Silk egel fibers were drawn from an ice bath after undergoing one heating (60° C.) and quenching ( ⁇ 0° C.) cycle.
  • FIG. 9 shows egel being formed on 3 platinum electrodes in a shortened Falcon tube. As shown, only one negative electrode is necessary.
  • the silk egel was placed in a 10 ml plastic syringe and heated to above 60° C. with a heat gun set to medium. The egel was extruded through the needle end of the syringe (no needle attached) into an ice bath, as shown in FIG. 10 a . As before, the egel material would tend to form a vertical underwater “fiber” that would stay suspended in the water.
  • FIG. 10 b shows a fiber immediately after being drawn.
  • FIG. 10 c shows a fiber tensioned between two insulated wires after about 30 min of air drying. Note that the beads that appear initially on the drawn fiber tend to dissipate with drying. Pulling on the fiber shows the fiber to be impressively strong for its diameter. In addition, the fibers drawn from the ice bath are quite tough after drying.
  • FIG. 11 shows a stereo microscope image of one of the silk egel fibers that was drawn from the ice water bath. The bifurcations are likely water beads ( FIG. 10 b ) that have dried. In the straight segments between the bifurcations, the fiber diameter is approximately 100 ⁇ m. The fiber is noticeably transparent when viewed under a microscope.
  • FIG. 9 c A Fisher Scientific hot plate ( FIG. 9 c ) was used to heat milli-Q water to about 60° C.
  • Egel was formed using three platinum electrodes, as shown in FIGS. 9 a and 9 b .
  • the platinum electrodes with the egel attached were submerged in the heated water bath, as shown in FIG. 12 , seemingly causing the silk from the egel to separate from the gel's water content.
  • FIGS. 12 c and 12 d are studied closely, the silk material can be seen falling into a pool at the base of the beaker. Over a span of 5 min, most of the egel is removed from the electrodes.
  • a 93.31 mm-long dried fiber was suspended in an empty 4 L beaker, with a 133 mg weight attached, as shown in FIG. 14 a .
  • Boiling water was poured into the beaker and the fiber length was monitored with a camera ( FIGS. 14 b - e ).
  • Significant elongation was seen after the fiber was exposed to the hot steam for about 20 sec. The total elongation exceeded approximately 35% of the original fiber length. After removal of humidity generated by the steam, the fiber contracted almost completely to its original length of about 93 mm.
  • a custom-designed and-built humidity chamber was fabricated for studying small-contraction cycling. Using 1 ⁇ 8′′ acrylic, a 24 ⁇ 24 ⁇ 24 in3 chamber was fashioned.
  • a Kaz Model V5100NS Ultrasonic Humidifier shown in FIG. 15 , was positioned inside the chamber, with a capability of bringing the internal humidity from room ambient relative humidity (around 44%) to about 95%. Because the humidifier uses ultrasonic energy to create a humid mist, the chamber temperature does not change appreciably from ambient temperature (around 26° C. on this day of testing).
  • a Lufft C200 hand-held humidity/temperature measurement device was used to monitor chamber conditions.
  • a drawn egel fiber (a quenched fiber) was suspended from the top of the chamber, with a 33 mg weight attached to the end with laboratory-grade tape.
  • the initial fiber length was about 15 cm, as seen in FIG. 16 a .
  • the ultrasonic humidifier was turned on. In a span of about 2 min, the relative humidity inside the chamber increased from ambient humidity (around 44%) to about 95%.
  • FIG. 16 b horizontal lines added for clarity
  • the humidity increased to about 95%
  • the drawn egel fiber elongated approximately 1.2 cm, which is about an 8% increase from the original length.
  • results showed that the egel fibers were all significantly stiffer than the cocoon fiber.
  • the fibers that had undergone humidity cycles with an ultrasonic humidifier exhibited unique load-extension response from the other two drawn egel samples: while all egel fibers exhibited an initially steep linear elastic response, the cycled fibers exhibited significant plastic strain after a peak load was reached.
  • the virgin silk egel fiber and fiber that was cycled with hot steam both failed catastrophically after their peak load was reached.
  • Table 2 shows the diameter and peak tensile stress for each fiber tested. In general, the smaller the fiber, the greater the tensile strength. This is consistent with published results from both cocoon silk and regenerated silk fibroin fibers and is likely due to heightened alignment that occurs with the draw-down of the fiber diameter.
  • the drawn egel fiber that had undergone humidity cycling with heated steam was, by far, the strongest. It exhibited much higher strength than cocoon fiber.
  • FIG. 21 b shows images of three drawn egel fibers: a fiber that had undergone humidity cycles with an ultrasonic humidifier; a virgin drawn egel fiber; and a fiber that had undergone quenching in an ice bath before drawing. Given all fibers have been drawn by hand, the fiber diameters vary and there are bifurcations, or bulges, that can be retained by the fiber. All of the fibers appear to be transparent, thus light can be transmitted through them.

Abstract

The present invention relates to compositions and method for drawing egel silk fibroin fibers. The resulting fibers can transmit light and hence can be used as optical fiber. Silk fibroin fiber is produced by a method comprising applying an electric field to a solubilized silk fibroin solution to create a silk fibroin gel; converting the silk fibroin gel to a viscous silk liquid; and drawing a silk fiber from the viscous silk liquid. The silk fiber of the invention can be used in materials such as textile, medical sutures, and tissue materials, as well as conferring optical properties into these materials.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. §371 National Phase Entry Application of International Application No. PCT/US2010/50565 filed Sep. 28, 2010, which designates the U.S., and which claims benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61/246,323 filed Sep. 28, 2009, the content of which is incorporated herein by reference in its entirety.
GOVERNMENT SUPPORT
This invention was made with government support under EB002520 awarded by the National Institutes of Health, under FA9550-07-1-0079 awarded by the U.S. Air Force, and under W911SR-08-C-0012 awarded by the U.S. Army Research, Development and Engineering Command Acquisition Center. The U.S. government has certain rights in the invention.
FIELD OF THE INVENTION
This invention provides for compositions and methods for drawing egel silk fibroin fibers. The resulting fibers can transmit light and hence can be used as optical fiber. Moreover, the silk fiber of the invention can be used in materials such as textile, medical sutures, and tissue materials, as well as conferring optical properties into these materials.
BACKGROUND
Optical fibers are typically flexible glass rods as thin as hair, which act as “wires” transmitting light or other data. In simple terms, they work by totally reflecting the light inside so that none of it leaks out. Synthetic polymer optical fibers are typically formed by extruding a viscous liquid through a small orifice called a spinneret. The viscous liquid is turned into a continuous filament which can be further solidified using post-extrusion processing.
One of the most useful characteristics of optical fibers is their ability to enter the minute passageways and hard-to-reach areas of the human body. Fiber optics has made important contributions to the medical field, especially with regards to surgery. This has been accomplished by cutting and polishing the ends of a very slim bundle of fibers, to form a fiberscope. The light is sent to the site of inquiry, reflected off of the area that the doctor wishes to see, and sent back to a receiver. Afterwards, the image is magnified to be analyzed. Because optical fibers are so flexible, they are able to navigate around the curvy parts of the human body in areas such as the stomach, heart, blood vessels, and joints. It is now even becoming possible to do surgery with instruments attached to the optical fibers, such as joint surgeries. Fiber optics is becoming especially important in heart surgery, since it can be done without disturbing the functions of this delicate organ.
A desirable alternative to glass or synthetic fibers would be a natural polymer fiber that is biodegradable, biocompatible, made by relatively simple techniques from renewable sources and aqueous procedures, can transmit light, and can also be weaved as conventional fibers into textiles, medical sutures, implantable tissue materials and in the mean time conferring optical properties to these materials.
SUMMARY
Silk electrogelation (egel) is a processing modality for silk fibroin protein. In simple terms, the egel process applies an electric field to solubilized silk fibroin solution, causing a transformation of the silk solution's random coil conformation into a meta-stable, silk I conformation. The resulting gel-like substance has many interesting properties, including muco-adhesive qualities and the ability to be further transformed into other conformations, including back to a random coil conformation or to an even higher-order β-sheet conformation.
The silk fibers in accordance with the present invention may be manufactured without the need for high-temperature furnaces and the large expense of conventional systems. A silk fiber in accordance with the present invention uses a silk fibroin gel as a base material to create fibers with improved mechanical properties, such as, for example, shear strength.
Further, silk fibers in accordance with the present invention are biocompatible, biodegradable and implantable. The silk fiber produced with the method of the invention is transparent and can transmit light, and thus can be used as an optical fiber. Accordingly, the silk fibers may be used to monitor health conditions in vivo or may be implanted as a part of a sensing system to monitor and transmit information related to disease processes, treatment efficacy, and tissue growth. The silk fibroin gel in accordance with the present invention may be used as a coating for any number of optical fiber and transmission media devices.
Additionally, silk fibers of the invention can be incorporated in textile-based components or structures, such as mats, yarns, and braids, to provide the smart-structure or smart-material enhancement of carrying sensor or computational data through the structure, due to the light transmission properties of the silk fiber. One such application could be a soft robot body containing silk optical fiber, in which sensor data is transmitted through the body wall, without the need for traditional wiring. Silk optical fibers can be used as sensors, such as in the measurement of curvature in biomechanical applications (such as a spine) or in measuring structure and building deformation (such as bridges or buildings in normal or severe weather or under unusual loading, such as in an earthquake).
The methods of producing silk egel fibers include an electrogelation process such as: applying an electric field (e.g., 25 VDC) to platinum electrodes submerged in solubilized silk solution. After a suitable time of electric field application (e.g., 10 minutes), a gel-like material has formed on the positive electrode, which has an increased level of meta-stable silk I conformation. When this silk gel is placed into a heated water bath, the gel dissociates into a fairly viscous liquid that settles at the bottom of the water bath. This viscous fluid can then be drawn out of the water bath to form a long fiber with unique mechanical properties and adjustable cross-section. The drawn fibers may be tougher if the dissociated gel is quenched in sub-zero temperature water (water which contains salt and crushed ice) before drawing into room-temperature air environment. In addition, the behavior of the fibers in a humid environment is consistent with the elongation/contraction response that is reported in spider silks. Importantly, the drawn egel fiber transmits light.
Silk egel fiber drawing creates silk fibers with robust mechanical properties. Given the ability to artificially create fibers with customized properties and size provides for many applications. For example, all-silk composite materials can be constructed from silk fibroin solutions, eliminating the need for traditional spooled silk fibers.
Moreover, the drawn silk fibers exhibit supercontraction when fully hydrated. Furthermore, the fibers exhibit reversible stretching and contraction under humidity cycling. Accordingly, silk fibers may be useful as an analog to muscle fibers to make artificial muscles, actuators for small and/or biomimetic robots, or for other applications such as drug release.
Additionally, because the drawn fibers transmit light, there are many potential applications for a silk optical fiber. For example, the fiber can be used in vivo to monitor health conditions, implanted as part of a sensing system to monitor healing, or incorporated in tissue engineering constructs to relay information on tissue ingrowth and scaffold degradation. As in traditional optical fiber applications, silk fibers can be used for long-range or short-range communication, in illumination, or laser-based applications. Because silk is biodegradable, the optical fiber would eventually degrade and absorb into the body.
In one aspect, then, described herein is a method of creating a silk fiber comprising: applying an electric field to a solubilized silk fibroin solution to create a silk fibroin gel; quenching the silk fibroin gel in water to generate a viscous silk liquid; and drawing the silk fibroin gel from the viscous silk liquid to create a silk fiber. In one embodiment, the water has a temperature at or below 0° C. In another embodiment, the water has a temperature in the range from 40° C. to 80° C., inclusive.
In another embodiment, the drawing of the silk is performed at a temperature within the range of 10° C. to 40° C., inclusive.
In another embodiment, the method further comprises drying the silk fiber.
In another embodiment, the method further comprises contracting the silk fiber. In one embodiment, contracting the silk fiber includes reducing the ambient humidity to which the silk fiber is exposed.
In another embodiment, the method further comprises expanding the silk fiber. In one embodiment, expanding the silk fiber includes increasing the ambient humidity to which the silk fiber is exposed.
In another embodiment, the silk fiber is processed with a methanol treatment to generate a water-insoluble silk fiber.
In another embodiment, the method further comprises wrapping a plurality of silk optical fibers.
In another embodiment, the silk fiber is an optical fiber.
In another embodiment, the method further comprises forming a fiber optic cable with the silk optical fiber.
In another embodiment, the method further comprises receiving, by the silk optical fiber, incident light from a light source.
In another embodiment, the silk optical fiber is a waveguide.
In another embodiment, the silk optical fiber is a single mode fiber. In another embodiment, the silk optical fiber is a multi-mode fiber.
DESCRIPTION OF THE DRAWINGS
FIGS. 1A-1D show a series of photographs presenting a time lapse sequence showing effects of submerging electrogelated silk (egel) in 60° C.-75° C. water: (1A) 5 seconds; (1B) 15 second; (1C) 25 seconds; and (1D) 35seconds.
FIG. 2 is a photograph showing formation of silk egel “structures” in 60° C.-75° C. water.
FIGS. 3A-3D show a series of time lapse photographs showing fiber drawing of egel from a 60° C.-70° C. water bath.
FIGS. 4A-4C show silk egel (4A) before heating; (4B) with heat gun; and (4C) after heating to about 60° C.
FIGS. 5A-5C show silk egel: (5A) before heating; (5B) in water bath to cool down; and (5C) after extrusion from syringe.
FIGS. 6A-6B show heated silk egel quenched in an ice bath: (6A) after initial quenching; and (6B) after about 1 minute.
FIGS. 7A-7B depict a custom fixture for exploration of light carrying capability of drawn silk egel fiber: (7A) overall setup; and (7B) zoomed image of fiber holder.
FIGS. 8A-8B presents images that demonstrate the ability for the drawn silk egel fibers to transmit light: (8A) light projects from the end of the drawn silk egel fiber; and (8B) bent fiber is glowing with light.
FIGS. 9A-9C show images of (9A) initial egel formation; (9B) after 5 minutes of electrogelation; and (9C) overview of power supply, egel tube setup, IR thermometer for recording temperature, and hot plate.
FIGS. 10A-10C depicts egel silk fiber drawing from a ice water bath: (10A) quenching of heated egel into an ice bath; (10B) a egel silk fiber immediately after being drawn from the bath (using an insulated wire); and (10C) a drawn egel silk fiber after some drying in air.
FIG. 11 is a stereo microscope image of a typical egel silk fiber drawn from an ice water bath and dried in ambient air. The diameter between the bifurcations is approximately 100 μm.
FIG. 12 shows time-lapse photographs of egel silk fibroin submerged in about 60° C. water. Over about a 5 minute period, the silk structure in the gel appears to separate from the water content, falling into a pool at the base of the beaker.
FIGS. 13A-13E show egel silk fiber drawn from a heated bath: (13A-13B) insulated wire dragging through silk pool; (13C-13D) fiber drawn rapidly from the bath.
FIGS. 14A-14E are time-lapse photographs of a weighted drawn silk egel fiber: (14A) fiber at ambient humidity with 133 mg weight attached; and (14B-14E) elongation of fiber after 20 seconds of exposure to steam.
FIG. 15 shows an example humidity chamber showing the Kaz Ultrasonic Humidifier (right), Lufft humidity/temperature device (center), and drawn egel fiber hanging next to a metric scale (left).
FIG. 16A-16C depicts drawn silk egel fiber exposed to dry humidity: (16A) initial fiber length of about 15 cm with 33 mg weight attached at ambient humidity of 44.5%; (16B) at 94.6% humidity; and (16C) after evacuation to 47.8% humidity.
FIGS. 17A-17B exhibits the change in drawn silk egel fiber length: (17A) from 81.7% humidity to (17B) 94.6% humidity.
FIGS. 18A-18D represents a comparison of drawn egel silk fiber contraction at relative humidity levels: (18A) 99.7%; (18B) 86.3%; (18C) 71.8%; and (18D) 62.4%.
FIG. 19 shows cardboard-mounted fibers positioned in Instron pneumatic grips for tensile tests.
FIG. 20 is a graph showing a comparison of load-extension response between several drawn silk egel fibers.
FIG. 21A-21B is a stereo microscope and images of three drawn egel fibers produced under unique conditions (1 mm scale bar).
FIGS. 22A-22B shows scanning electron microscope (SEM) images of a drawn egel fiber: (22A) at 1560×; and (22B) 1960× magnification.
DETAILED DESCRIPTION
Synthetic polymer fibers are typically formed by extruding a viscous liquid through a small orifice called a spinneret. The viscous liquid is turned into a continuous filament which can be further solidified using post-extrusion processing. Four spinning methods are prevalent, including wet, dry, melt, and gel spinning. Wet spinning is used on materials that are dissolved in a solvent. The filaments are drawn through a spinneret that is submerged in a chemical bath that acts as a precipitating liquid. Dry spinning is also employed on materials in solution. In contrast, solidification occurs as the solvent is driven off by gas (e.g., air)-driven evaporation. Melt spinning involves the extrusion of melted material through a spinneret and solidification by cooling. Gel spinning, the most relevant process to the experiments described herein, is performed on a material that is not a true solution; polymer chains are bound together in liquid crystal form. By virtue of the inter-chain forces that develop and the alignment of the liquid crystals by shear forces during extrusion, resulting filaments can attain a high degree of alignment and greatly improved tensile strength.
Optical fibers are transmission media that carry an optical signal from a light source to, for example, an optical receiver of that signal. Optical fibers and fiber optic cables may be used to transmit signals such as voice, video, and data signals. The data signal from a communication signal source such as a telephone or data modem is modulated onto a light wave and transported via the optical fibers to the optical receiver. The data signal is then recovered at the receiver using a demodulation process.
Conventional optical fibers require protective coverings to protect silica-based optical fibers and to preserve their optical performance. The fiber optic cables must be protected from external forces such as tensile forces as well as from macro-bending and micro-bending to ensure satisfactory optical performance. Fiber optic cables and their optical fibers have inherent signal attenuation characteristics. Signals transmitted via an optical fiber are attenuated as they travel, and at some distance from the light source the signals reach a sufficiently low level as to require amplification.
Conventional glass optical fibers are typically made by either a crucible method, where powdered silica is melted, or by a vapor deposition process. Crucible methods may be used to produce large diameter multimode fibers suitable for short-distance transmission of many light wave signals. Vapor deposition processes are used to create a solid cylinder of core and cladding material that is then heated and drawn into a thinner optical fibers for longer distance communication.
The ability of silk fibroin films and other structures in optics has been explored, for example, in WO 2008/118211, Biopolymer Photonic Crystal & Method of Manufacturing the Same; WO 2008/127401, Biopolymer Optical Waveguide & Method of Manufacturing the Same; and WO 2008/140562, Electoreactive Biopolymer Optical & Electro-Optical Devices & Methods of Manufacturing the Same.
Silk electrogelation (egel) is a processing modality for silk fibroin protein. In simple terms, the egel process applies an electric field (either direct or alternating current, referred to as DC or AC) to solubilized silk fibroin solution, causing a transformation of the silk protein's random coil conformation into a meta-stable, silk I conformation. The electric field can be applied through using a voltage source, such as a DC or AC voltage source. Direct current is produced by sources such as batteries, thermocouples, solar cells, etc. Alternatively, alternating current (AC), the general powder source for business and residence, may also be used to induce the electrogelation process, although the gel formation may not be as fast as the gelation process induced by direct current voltage. Other methods of applying an electric field to the silk solution may also be used, such as current sources, antennas, lasers, and other generators. The resulting gel-like substance has a very sticky, thick, mucus-like consistency and has many interesting properties, including muco-adhesive qualities and the ability to be further transformed into other conformations, including back to a random coil conformation or to an even higher-order β-sheet conformation. The method of eletrogelation, the related parameters used in the eletrogelation process and the structural transition of silk fibroin during the electrogelation process may be found in WO/2010/036992, Active silk muco-adhesives, silk electrogelation process, and devices, which is incorporated herein as a reference in its entirety.
As used herein, the term “silk fibroin” includes silkworm fibroin and other insect or spider silk protein (Lucas et al., 13 Adv. Protein Chem. 107-242 (1958)). Silk fibroin can be obtained from a solution containing a dissolved silkworm silk or spider silk. The silkworm silk fibroins are obtained, for example, from the cocoon of Bombyx mori, and the spider silk fibroins are obtained, for example, from Nephila clavipes. In the alternative, the silk fibroins suitable for use in the present invention can be obtained from a solution containing a genetically engineered silk harvested from bacteria, yeast, mammalian cells, transgenic animals or transgenic plants. See, e.g., WO 97/08315 and U.S. Pat. No. 5,245, 012.
An aqueous silk fibroin solution may be prepared from the silkworm cocoons using techniques known in the art. Suitable processes for preparing silk fibroin solution are disclosed in, for example, U.S. patent application Ser. No. 11/247,358, WO/2005/012606, and WO/2008/127401. The concentration of silk fibroin aqueous solution may by decreased by dilution, or increased by dialyzing a lower concentration silk fibroin solution against a hygroscopic polymer, for example, PEG, a polyethylene oxide, amylose or sericin. See, e.g., WO 2005/012606. Optionally, the resulting silk solution may be further processed, e.g., through centrifugation or micro-filtration, to remove remaining particulates and to reach to a silk fibroin solution with minimal contaminants and reduced scattering for optical applications.
The embodiments described herein provide for a silk egel fiber drawing process. The several Examples describe experiments conducted to provide alternative fabrication strategies for silk egel fiber drawing. The results of these experiments show the potential for creating fibers with a range of cross-sections and potentially impressive mechanical properties. The process is aqueous-based and easily set up and executed on a lab bench. The fibers generated can be long, and the process can be both continuous and automated. It appears that a wide range of diameters can be produced. The solubility of the dried fiber can be changed by a post-processing treatment to generate water-insoluble conformations. For example, an alcohol treatment (e.g., methanol treatment) or water annealing treatment of the silk fibers, which can be included as part of a continuous processing approach, can provide water-insoluble silk fibers. The ability to drive the fiber diameters to very small cross sections could impart strength through the alignment of molecular chains along the fiber axis. Additionally, the use of an underwater spinneret may contribute to this strengthening effect. The use of the egel is key in generating fibers that rival the mechanical performance of native silkworm silk fiber. In addition, the silk conformation achieved with electrogelation may match the precursor gel-phase present in the glands of living silkworms and spiders before being extruded through spinnerets.
This process of fiber drawing may mimic the native process, leading to superior outcomes to all other fiber formation processes using regenerated silk. See, e.g., Zhou et al., Silk Fibers Extruded Artificially from Aqueous Solutions of Regenerated Bombyx mori Silk Fibroin are Tougher than their Natural Counterparts, 21 Adv. Mats. 366-70 (2009). Indeed, the drawn egel silk fibers can be very strong—the smallest-diameter fibers made by the techniques taught herein show higher strength than cocoon fiber.
The silk fiber made by the method of the present invention is quite transparent, can transmit light, such as a laser light, and therefore can be used as optical fiber.
The embodiments of the present invention thus provide for a method of forming an silk fiber comprising applying an electric field to a solubilized silk fibroin solution, transforming the solubilized silk fibroin solution to a silk gel based upon the applied electric field, converting the silk fibroin gel to a viscous silk liquid (e.g., quenching the silk gel water to generate a viscous silk liquid), and drawing the silk liquid to form a silk fiber. Optionally, the silk fibroin gel may be heated prior to the quenching step, and the silk fibroin gel may be heated to a temperature higher than the temperature of water used in the quenching step. For example, the silk fibroin gel may be heated to about 60° C., and quenched in a cool water bath (temperature of the water bath is lower than 60° C., such as ˜0° C.). The drawing may be done in water having a temperature at or below 0° C.; in the range from 40° C. to 80° C.; or within the range of 10° C. to 40° C. The method may further include drying the silk fiber. The dried silk fiber is quite transparent and exhibits transmission of laser light.
The silk fiber may also be contracted, such as by reducing the ambient humidity to which the silk fiber is exposed; or expanded, such as by increasing the ambient humidity to which the silk fiber is exposed. Additionally, the silk fiber may be further processed, for example with a methanol treatment, to generate water-insoluble silk fiber.
In one embodiment, the silk fiber is used as optical fiber. The method may also further include forming a fiber optic cable with a silk optical fiber or a plurality of silk optical fibers.
Additionally, the silk optical fiber of the present invention may receive incident light from a light source; and may act as a waveguide, a multimode fiber, or a single mode fiber. A plurality of silk optical fibers may be wrapped into a fiber optic cable by techniques well-known in the art.
Silk fibers produced from the method of the invention may be wrapped with other type of fibers made from silk or other materials, natural or synthetic, into a fiber bundle or fiber composite. For example, a fiber composite may be made from one or more silk fibers of the invention combined with one or more native silkworm fibroin fibers to form a silk-fiber-based matrix. Immunogenic components in the silk (such as sericin) may be removed from native silk fiber if such silk fiber based matrix is to be used as implantable materials. These silk fiber based matrix may be used to produce tissue materials for surgical implantation into a compatible recipient, e.g., for replacement or repair of damaged tissue. Some non-limiting examples of tissue materials that can be produced include ligaments or tendons such as anterior cruciate ligament, posterior cruciate ligament, rotator cuff tendons, medial collateral ligament of the elbow and knee, flexor tendons of the hand, lateral ligaments of the ankle and tendons and ligaments of the jaw or temporomandibular joint; cartilage (both articular and meniscal), bone, muscle, skin and blood vessels. Methods of making tissue materials or medical device using silk-fiber based matrix or silk composite containing silk fibers may be found in, e.g., U.S. Pat. No. 6,902,932, Helically organized silk fibroin fiber bundles for matrices in tissue engineering; U.S. Pat. No. 6,287,340, Bioengineered anterior cruciate ligament; U.S. Patent Application Publication Nos. 2002/0062151, Bioengineered anterior cruciate ligament; 2004/0224406, Immunoneutral silk-fiber-based medical devices; 2005/0089552, Silk fibroin fiber bundles for matrices in tissue engineering; 20080300683, Prosthetic device and method of manufacturing the same; 2004/0219659, Multi-dimensional strain bioreactor; 2010/0209405, Sericin extracted silkworm fibroin fibers, which are incorporated by reference in their entirety.
Silk fibers produced from the method of the invention may be incorporated into textile (e.g., yarns, fabrics) and textile-based structures using traditional textile-processing equipment, including winding, twisting, flat braiding,weaving, spreading, crocheting, bonding, tubular braiding, knitting, knotting, and felting (i.e., matting, condensing or pressing) machines. Such textiles can be incorporated in composite materials and structures through many known composite-manufacturing processes.
Silk fibers produced from the method of the invention may be combined with other forms of silk material, such as silk films (WO2007/016524), coatings (WO2005/000483; WO2005/123114), microspheres (PCT/US2007/020789), layers, hydrogel (WO2005/012606; PCT/US08/65076), mats, meshes, sponges (WO2004/062697), 3-D solid blocks (WO2003/056297), etc., to form an all-silk composite. The silk composite material can be reinforced by silk fiber, as well as incorporate the optical property of silk optical fiber into the composite. For example, a one, two or three-dimensional silk composite may be prepared by exposing silk fiber with silk fibroin solution and drying or solidifying the silk fibroin solution containing the silk fiber of the invention to form the silk composite. Different solidifying processes and additional approaches for processing silk fibroin solution into different formats of silk materials can be used. See, e.g., WO/2005/012606; WO/2008/150861; WO/2006/042287; WO/2007/016524; WO 03/004254, WO 03/022319; WO 04/000915.
Moreover, silk fiber produced by the method of the invention can be combined with one or more other natural or synthetic biocompatible or non-biocompatible polymers, and incorporated into a composite with different material formats, such as fibers, films, coatings, layers, gels, mats, meshes, hydrogel, sponges, 3-D scaffold, and the like. The non-limiting biocompatible polymers include polyethylene oxide, polyethylene glycol, collagens (native, reprocessed or genetically engineered versions), polysaccharides (native, reprocessed or genetically engineered versions, e.g. hyaluronic acid, alginates, xanthans, pectin, chitosan, chitin, and the like), elastin (native, reprocessed or genetically engineered and chemical versions), agarose, polyhydroxyalkanoates, pullan, starch (amylose amylopectin), cellulose, cotton, gelatin, fibronectin, keratin, polyaspartic acid, polylysin, alginate, chitosan, chitin, poly lactide, poly glycolic, poly(lactide-co-glycolide), poly caproloactone, polyamides, polyanhydrides, polyaminoacids, polyortho esters, poly acetals, proteins, degradable polyurethanes, polysaccharides, polycyanoacrylates, glycosamino glycans (e.g., chrondroitin sulfate, heparin, etc.), and the like. Exemplary non-biodegradable polymers include polyamide, polyester, polystyrene, polypropylene, polyacrylate, polyvinyl, polycarbonate, polytetrafluorethylene and nitrocellulose material. When incorporating silk fiber into the composite, one or more of these aforementioned polymers can be combined. See also, e.g., U.S. Pat. No. 6,902,932; U.S. Patent Application Publication Nos. 2004/0224406; 2005/0089552; 2010/0209405.
The geometry and properties of composite materials containing the silk fiber of the invention can be tailored to specific applications. For example, single fiber layers have been shown to be very tough and flexible. Cylindrical mandrels can be used to produce very stiff rod or tubular constructs that can have impressive compressive, tensile, flexural, and torsional properties. Custom wavy or highly curved geometries can also be produced.
The composite material generally enhances the matrix properties such as mechanical strength, porosity, degradability, and the like, and also enhances cell seeding, proliferation, differentiation or tissue development when used as medical suture or implantable tissue materials.
Silk fibroin in the silk fiber can also be chemically modified with active agents in the solution, for example through diazonium or carbodiimide coupling reactions, avidin-biodin interaction, or gene modification and the like, to alter the physical properties and functionalities of the silk protein. See, e.g., PCT/US09/64673; PCT/US10/42502; PCT/US2010/41615; U.S. patent application Ser. No. 12/192,588.
Silk fiber of the invention may include at least one active agent. The agent may be embedded in the fiber or immobilized on the surface of the fiber. The active agent may be a therapeutic agent or biological material, such as chemicals, cells (including stem cells) or tissues, proteins, peptides, nucleic acids (e.g., DNA, RNA, siRNA), nucleic acid analogues, nucleotides, oligonucleotides or sequences, peptide nucleic acids(PNA), aptamers, antibodies or fragments or portions thereof (e.g., paratopes or complementarity-determining regions), antigens or epitopes, hormones, hormone antagonists, cell attachment mediators (such as RGD), growth factors or recombinant growth factors and fragments and variants thereof, cytokines, enzymes, antioxidants, antibiotics or antimicrobial compounds, anti-inflammation agents, antifungals, viruses, antivirals, toxins, prodrugs, drugs, dyes, amino acids, vitamins, chemotherapeutic agents, small molecules, and combinations thereof. The agent may also be a combination of any of the above-mentioned active agents.
Exemplary antibiotics suitable for use herein include, but are not limited to, aminoglycosides (e.g., neomycin), ansamycins, carbacephem, carbapenems, cephalosporins (e.g., cefazolin, cefaclor, cefditoren, cefditoren, ceftobiprole), glycopeptides (e.g., vancomycin), macrolides (e.g., erythromycin, azithromycin), monobactams, penicillins (e.g., amoxicillin, ampicillin, cloxacillin, dicloxacillin, flucloxacillin), polypeptides (e.g., bacitracin, polymyxin B), quinolones (e.g., ciprofloxacin, enoxacin, gatifloxacin, ofloxacin, etc.), sulfonamides (e.g., sulfasalazine, trimethoprim, trimethoprim-sulfamethoxazole (co-trimoxazole)), tetracyclines (e.g., doxycyline, minocycline, tetracycline, etc.), chloramphenicol, lincomycin, clindamycin, ethambutol, mupirocin, metronidazole, pyrazinamide, thiamphenicol, rifampicin, thiamphenicl, dapsone, clofazimine, quinupristin, metronidazole, linezolid, isoniazid, fosfomycin, or fusidic acid.
Exemplary cells suitable for use herein may include, but are not limited to, progenitor cells or stem cells (e.g., bone marrow stromal cells), ligament cells, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, epithelial cells, endothelial cells, urothelial cells, fibroblasts, myoblasts, chondrocytes, chondroblasts, osteoblasts, osteoclasts, keratinocytes, hepatocytes, bile duct cells, pancreatic islet cells, thyroid, parathyroid, adrenal, hypothalamic, pituitary, ovarian, testicular, salivary gland cells, adipocytes, and precursor cells.
Exemplary antibodies include, but are not limited to, abciximab, adalimumab, alemtuzumab, basiliximab, bevacizumab, cetuximab, certolizumab pegol, daclizumab, eculizumab, efalizumab, gemtuzumab, ibritumomab tiuxetan, infliximab, muromonab-CD3, natalizumab, ofatumumab omalizumab, palivizumab, panitumumab, ranibizumab, rituximab, tositumomab, trastuzumab, altumomab pentetate, arcitumomab, atlizumab, bectumomab, belimumab, besilesomab, biciromab, canakinumab, capromab pendetide, catumaxomab, denosumab, edrecolomab, efungumab, ertumaxomab, etaracizumab, fanolesomab, fontolizumab, gemtuzumab ozogamicin, golimumab, igovomab, imciromab, labetuzumab, mepolizumab, motavizumab, nimotuzumab, nofetumomab merpentan, oregovomab, pemtumomab, pertuzumab, rovelizumab, ruplizumab, sulesomab, tacatuzumab tetraxetan, tefibazumab, tocilizumab, ustekinumab, visilizumab, votumumab, zalutumumab, and zanolimumab.
Exemplary enzymes suitable for use herein include, but are not limited to, peroxidase, lipase, amylose, organophosphate dehydrogenase, ligases, restriction endonucleases, ribonucleases, DNA polymerases, glucose oxidase, laccase, and the like.
Additional active agents to be used herein include cell growth media, such as Dulbecco's Modified Eagle Medium, fetal bovine serum, non-essential amino acids and antibiotics; growth and morphogenic factors such as fibroblast growth factor, transforming growth factors, vascular endothelial growth factor, epidermal growth factor, platelet derived growth factor, insulin-like growth factors), bone morphogenetic growth factors, bone morphogenetic-like proteins, transforming growth factors, nerve growth factors, and related proteins (growth factors are known in the art, see, e.g., Rosen & Thies, CELLULAR & MOLECULAR BASIS BONE FORMATION & REPAIR (R.G. Landes Co.); anti-angiogenic proteins such as endostatin, and other naturally derived or genetically engineered proteins; polysaccharides, glycoproteins, or lipoproteins; anti-infectives such as antibiotics and antiviral agents, chemotherapeutic agents (i.e., anticancer agents), anti-rejection agents, analgesics and analgesic combinations, anti-inflammatory agents, and steroids.
In some embodiments, the active agent may also be an organism such as a bacterium, fungus, plant or animal, or a virus. Moreover, the active agent may include neurotransmitters, hormones, intracellular signal transduction agents, pharmaceutically active agents, toxic agents, agricultural chemicals, chemical toxins, biological toxins, microbes, and animal cells such as neurons, liver cells, and immune system cells. The active agents may also include therapeutic compounds, such as pharmacological materials, vitamins, sedatives, hypnotics, prostaglandins and radiopharmaceuticals.
Additional applications for silk optical fibers drawn from silk egels include photomechanical actuation, electro-optic fibers, and smart materials.
When the silk fibers of the present invention is used in the textile, medical suture materials or tissue materials, either separately or combined into a composite, stimulus can be incorporated in the aforementioned method of producing the textile medical suture materials or tissue materials. For example, chemical stimuli, mechanical stimuli, electrical stimuli, or electromagnetic stimuli can also be incorporated herein. Because the silk fiber of the invention possess light-transmission property, the silk fiber contained in the textile, medical suture materials or tissue materials can be used to transmit the optical signals that may be from the stimuli or converted from the stimuli originated from the environment (e.g., tissue, organ or cells when used as implant materials) and influence the properties of the textile, suture or tissue materials. Alternatively, silk optical fiber may be used to transmit the optical signal to the applied medium, such as cells or tissues when used as implant materials, and modulate the activities of the cells or tissues. For example, cell differentiation is known to be influenced by chemical stimuli from the environment, often produced by surrounding cells, such as secreted growth or differentiation factors, cell-cell contact, chemical gradients, and specific pH levels, to name a few. Some stimuli are experienced by more specialized types of tissues (e.g., the electrical stimulation of cardiac muscle). The application of such stimuli that may be directly or indirectly transmitted by optical signal is expected to facilitate cell differentiations.
Additionally, a controlled drug delivery system may be made available by incorporating the silk optical fiber into the system, for example, the drug administration and release can be controlled in a manner that precisely matches physiological needs through the external stimuli applied on the silk optical fiber.
In physics, there is a phenomenon called refraction, where light “bends” upon entering medium with different indexes of refraction. There is a certain angle, called the critical angle, at which a light ray can enter the first medium and then travel between the two mediums, without crossing into the second medium. If the angle at which the ray passes through the first medium is greater than the critical angle, the ray will experience total internal reflection, where it will just reflect off the surface between the two mediums and reenter the first medium. This is the case with contemporary optical fibers. The silk optical fiber of the present embodiments is well-able to conduct light while bent, as shown in FIG. 8 b.
The silk-based optical fibers of the present invention may be used, for example, in systems for endoscopy which combine fiber optics and powerful lenses. The medical device may include objective lenses, rod lenses, ocular lenses, light fibers, light source, camera for imaging. A micro-camera may be attached to the eyepiece and an image viewed on a monitor. The endoscopy system may use charge-coupled devices that capture and store image data. For example, a 2D array of individual elements that can store an electric charge, and can respond to 70% of the incident light. Light sourced include tungsten filament lamp, halogen reflector lamp, rare-earth xenon lamp give high intensity light and true color display (xenon daylight effect). The typical flexible endoscope has a bending radius of about 15 mm and two silk fiber optic cables: one is a light conduit (incoherent), second is used to image transmission (coherent). The image fiber may have an image resolution of approximately 10,000 pixels per square mm. Applications for endoscopy include surgical imaging systems that can simulate the optimal path for the surgeon (e.g., inside the brain for neurosurgery). In laser, brain surgery within the skull, the endoscopic device is threaded like a wire through a one-eighth-inch incision in the skull, implanted in the tumor like a biopsy needle, and turned on for spurts of a few seconds.
Further regarding laser surgery, nonimaging edge-ray concentrators may be well suited to a number of laser fiber optic contact surgical procedures where sizable increases in irradiance are required at maximum collection efficiency, and light must be emitted uniformly over a wide angular range. Compared to earlier fiber optic devices developed for these tasks, the delivered irradiance from nonimaging designs can be more than double, at maximum radiative efficiency, while producing a Lambertian absorber, i.e., uniform emission over the entire hemisphere. Additional modifications of the egel drawing process are supported by the disclosure provided herein, including automation, that may improve the generation of controllable and consistent fiber diameters, and may eliminate the bifurcation anomalies. Further optimizing and characterizing silk egel drawing, improving the quality control of the fibers, generating improved light-carrying fibers, and exploring further the hydration-driven contraction and elongation are within the scope of the present invention.
Particular embodiments of the invention are described in non-limiting examples.
The present invention may be as defined in any one of the following numbered paragraphs:
    • 1. A method of producing a silk fiber comprising:
    • applying an electric field to a solubilized silk fibroin solution to create a silk fibroin gel;
    • converting the silk fibroin gel to a viscous silk liquid;
    • drawing a silk fiber from the viscous silk liquid.
    • 2. The method of paragraph 1, wherein converting the silk fibroin gel to the viscous silk liquid comprises quenching the silk fibroin gel in water.
    • 3. The method of paragraph 2, wherein the water has a temperature at or below 0° C.
    • 4. The method of paragraph 2, wherein the water has a temperature in the range from 40° C. to 80° C.
    • 5. The method of paragraph 2, wherein drawing the silk is performed at a temperature within the range of 10° C. to 40° C.
    • 6. The method of paragraph 2, wherein converting the silk fibroin gel to the viscous silk liquid further comprises heating the silk fibroin gel prior to the quenching step.
    • 7. The method of paragraph 6, wherein the silk fibroin gel is heated to a temperature higher than the temperature of water used in the quenching step.
    • 8. The method of paragraph 1, further comprising drying the silk fiber.
    • 9. The method of paragraph 1, further comprising contracting the silk fiber
    • 10. The method of paragraph 9, wherein contracting the silk fiber includes reducing the ambient humidity to which the silk fiber is exposed.
    • 11. The method of paragraph 1, further comprising expanding the silk fiber.
    • 12. The method of paragraph 11, wherein expanding the silk fiber includes increasing the ambient humidity to which the silk fiber is exposed.
    • 13. The method of paragraph 1, further comprising processing the silk fiber with an alcohol treatment or water annealing treatment to generate a water-insoluble silk fiber.
    • 14. The method of paragraph 1, further comprising wrapping a plurality of the silk fibers.
    • 15. The method of paragraph 1, further comprising wrapping at least one of the silk fibers with at least one other fiber.
    • 16. The method of paragraph 15, wherein the other fiber comprises at least one sericin-extracted silk natural fibroin fiber.
    • 17. The method of paragraph 1, further comprising incorporating at least one silk fiber into a composite.
    • 18. The method of paragraph 17, wherein the composite is all-silk composite.
    • 19. The method of any one of the proceeding paragraphs, wherein the silk fiber is an optical fiber.
    • 20. The method of paragraph 19, further comprising forming a fiber optic cable with the silk optical fiber.
    • 21. The method of paragraph 19, further comprising transmitting a light signal through the silk optical fiber.
    • 22. The method of paragraph 21, wherein the transmitting step comprises receiving, by the silk optical fiber, an incident light from a light source.
    • 23. The method of paragraph 21, wherein the transmitting step comprises receiving, by the silk optical fiber, a light signal converted from stimuli from the environment of the silk optical fiber.
    • 24. The method of paragraph 19, wherein the silk optical fiber is a waveguide.
    • 25. The method of paragraph 19, wherein the silk optical fiber is a multi-mode fiber.
    • 26. The method of paragraph 19, wherein the silk optical fiber is a single mode fiber.
    • 27. A composition prepared from the method of any one of the proceeding paragraphs.
It should be understood that this invention is not limited to the particular methodology, protocols, and reagents, etc., described herein and as such may vary. The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention, which is defined solely by the claims.
As used herein and in the claims, the singular forms include the plural reference and vice versa unless the context clearly indicates otherwise. Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients or reaction conditions used herein should be understood as modified in all instances by the term “about.”
All patents and other publications identified are expressly incorporated herein by reference for the purpose of describing and disclosing, for example, the methodologies described in such publications that might be used in connection with the present invention. These publications are provided solely for their disclosure prior to the filing date of the present application. Nothing in this regard should be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior invention or for any other reason. All statements as to the date or representation as to the contents of these documents is based on the information available to the applicants and does not constitute any admission as to the correctness of the dates or contents of these documents.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as those commonly understood to one of ordinary skill in the art to which this invention pertains. Although any known methods, devices, and materials may be used in the practice or testing of the invention, the methods, devices, and materials in this regard are described herein.
EXAMPLES Example 1 Effect of Elevated Temperature on Egel
Solubilized silk fibroin aqueous stock solutions were prepared as described previously. Sofia et al., 54 J. Biomed. Mater. Res. A 139-48 (2001). Briefly, cocoons of B. mori were boiled for 20 min in an aqueous solution of 0.02 M sodium carbonate, and then rinsed thoroughly with water (ultra-pure water processed via Milli-Q® Water System, Millipore, Billerica, Mass.). After drying, the extracted silk fibroin was dissolved in a 9.3 M LiBr solution at 60° C. for 4 hr, yielding a 20% (w/v) solubilized silk fibroin solution. The resulting solution was dialyzed against distilled water using Slide-A-Lyzer® 3.5K MWCO dialysis cassettes (Pierce, Rockford, Ill.) for three days to remove the residual salt. The solution was optically clear after dialysis and was centrifuged twice at 10,000 rpm for 20 min to remove silk aggregates as well as debris from original cocoons. The final concentration of solubilized silk fibroin aqueous solution was approximately 8% (w/v). This concentration was determined by drying the solution with a known volume and weighing the residual solid. The 8% silk fibroin solution was stored at 4° C. and diluted with water before use.
To explore the effects of heat on electrogelation, about 8% w/v solubilized silk fibroin solution was heated to about 60° C.-75° C. Using a “standard” egel setup that consists of the bottom half of a Falcon tube and two platinum (Pt) electrodes submerged in the heated solution, 25 VDC was applied with an Agilent 3364A power supply. Surprisingly, no visible gel formed on the positive electrode, which is the typical response in electrogelation. Perhaps the heating of silk solution somehow permanently affects the ability to perform electrogelation on the silk. Prior evidence supported this idea; an autoclaved volume of silk solution at 121° C. would not produce observable gel using electrogelation. The autoclaved silk solution “recovered” over time, however. After a week of storage at 5° C.-10° C., the autoclaved silk solution exhibited some electrogelation response, albeit reduced. As subsequent experiments appeared to suggest, the electrogelation of a heated silk solution may have changed the conformation of the silk solution from random coil to silk I, but that the material was not staying in contact with the positive (typically platinum) electrode.
Example 2 Effect of Elevated Temperature on Egel II
Electrogelated silk was first created in a “standard” setup (8% w/v silk solution, platinum electrodes, and Falcon tube as above). After 10 min of electrogelation, the gel which formed on the positive electrode was transferred to a beaker containing water heated to 60° C.-75° C. FIG. 1 shows images of the gel response at 10 sec time intervals. Upon immersion in the warm water, the egel on the Pt seemed to dissociate and fall to the base of the beaker, apparently due a density differential. Simultaneously, any bubbles trapped in the egel rose to the water surface as they were released. The dissociation process continued until it appeared only β-sheet material was remaining on the Pt electrode. It should be noted that over an extended period of electrogelation, the silk solution that is in closest proximity to the positive electrode at the start of electrogelation tends to continue to convert to an irreversible conformation (assumed to be β-sheet), while the vast majority of the gel attains a silk I conformation. The material collected on the base of the bath in a coherent viscous fluid puddle.
Example 3 Drawing of Egel Fiber I
Using the beaker of warm water and dissociated silk from Example 2, the utility of the curious material was explored. Using an insulated wire with a hook-shape tip, the viscous puddle of silk could be pulled upward in the heated water to form a “structure.” It was obvious when manipulating the material at varying bath temperatures that temperature is an important factor in maintaining a coherent structure. The structure itself had the consistency of seaweed being pulled from the surface of the ocean. As shown in FIG. 2, a series of “fibers” could be drawn up to the surface of the water. Interestingly, the “fibers” would stay in place. Perhaps this is due to the “fiber” ends attaching to impurities at the water surface, due to surface adhesion, or due to neutral buoyancy achieved when the stretched material approximately matched the density of the water. In this way, three-dimensional structures could be formed, including sheet-like geometries.
When one “fiber” is drawn out of the water bath, it can be stretched to very long lengths. One key appears to be the temperature of the water bath. Qualitative information showed that a bath temperature of about 60° C. generated the best results. At cooler temperatures, the “fiber” would break even before bringing it to the water surface. At higher temperatures, the “fiber” acts less viscous, which would prevent formation of a “fiber” at all. FIG. 3 shows time lapse photos of a “fiber” being drawn out of the heated bath. The fiber was drawn up at a rate of about 1 inch/second. Initial success led to fiber lengths of between 40 and 50 inches. The fiber lengths could be longer, depending on the amount of silk in the water, the temperature of the water, and the drawing rate. The drawn fibers were very sticky (if two fibers tangled, they would stick together). Over a period of minutes, the fiber would become thinner, less sticky, and more brittle. After between 40 min and 60 min, the fibers could be handled without becoming stuck to other surfaces or itself. Perhaps the solidification is due to a drying effect, where water entrained in the fiber was evaporating. After drying, the fibers had surprising strength, but would quickly become soft when rehydrated in water (especially warm water).
Example 4 Response of Egel to Temperature Swings
In this experiment, silk egel was placed in a 5 ml plastic syringe. Because egel has an increased silk I conformation over silk solution, which is meta-stable, the egel was placed in the syringe by first removing the syringe plunger and inserting from the plunger end of the syringe. If egel were drawn into the syringe through a syringe needle, flow-induced shear would likely cause some conformation change to β-sheet, which would fundamentally affect the experiment. The silk egel before heating is shown in FIG. 4 a. Using a heat gun on a medium heat setting (FIG. 4 b), the egel was heated above 60° C. While heating, the egel became a liquid. When the internal temperature approached 60° C., the entire volume of gel had become liquid, as shown in FIG. 4 c. After removal of the heat source, the liquid solution converted back to a gel, with very similar characteristics to egel. It appears that the reconstituted gel might be somewhat stickier than the original egel and more transparent in appearance. This implies that egel conformation and stickiness can be “turned on” and “turned off” through thermal cycling. In many applications this can be an attractive alternative to cycling using electrical charging with polarity reversal.
Example 5 Response of Egel to Temperature Cycling
In a follow-up experiment, the same egel-syringe-heat gun experiment was conducted, with one modification. The syringe plunger was modified by drilling an access hole, through which a small diameter, type T thermocouple was installed. FIG. 5 a shows the syringe and gel, with the thermocouple visible in the center of the image. This thermocouple was used to monitor temperature of the egel and liquid throughout the experiment with National Instruments' CompactDAQ data acquisition hardware and LabVIEW software. This experiment was conducted by performing two complete heating/cooling cycles. A heat gun was used for heating and a water bath for cooling (FIG. 5 b). After each phase of the experiment (after each heating and cooling cycle), a small volume of silk material was extracted from the needle end of the syringe (no needle attached), as shown in FIG. 5 c. Cycling appears to provide similar results after each cycle—a highly viscous and sticky gel forms upon cool-down, while a much less sticky, low viscosity liquid is formed above about 60° C. When manipulated by hand, the gel that formed after each cooling stage responded similarly to egel that was created before the heating/cooling cycles. The gel could be attached to a vertical surface and stay attached or be rolled into a rubbery ball. In simple terms, it appears that the silk conformation found in egel can be reversibly brought to a more random coil conformation and back again.
Example 6 Drawing of Egel Fiber II
Following the protocol from experiment 3 above, this experiment included the use of a type T thermocouple and National Instruments' CompactDAQ data acquisition hardware and LabVIEW software to monitor bath temperature. Silk egel was placed into a beaker of water heated to 60° C. After the egel would dissociate and sink to the bottom of the water bath, “fibers” of the liquid silk were drawn upward out of the bath. Depending on speed and height above the water bath, the fibers could be drawn to various diameters. After hanging each drawing fiber on a lab bench shelf, the initially sticky and non-uniform fiber would begin to dry/solidify. The fiber also tended to decrease in diameter and become more uniform. The final fibers exhibited impressive tensile properties, but were fairly brittle. If the dry fibers were wrapped into a curvature of less than about 90° C., they tended to fracture. Although the surface of the fiber was more smooth than after initial drawing, there were still noticeable bumps and rough sections on the fiber.
Additionally, after submerging a volume of egel into a 60° C. water bath, the bath was cooled to room temperature, the water was removed from the upper region of the water bath (separation between water and silk was visible), and the remaining material was left at room temperature overnight. After about 18 hours, the remaining material was observed to be a thin silk disc that was opaque white and very tough. It was very moist, but would become very brittle once the water was allowed to evaporate.
Example 7 Extrusion of Heated Egel and Quenching in an Ice Water Bath
As a way to speed up the formation of a fiber, an ice bath was created using a beaker of tap water and ice chips. The temperature was measured to be around 0° C. Using a 10 ml plastic syringe, silk egel was first heated to above 60° C. with a heat gun set to medium. The egel was extruded through the needle end of the syringe (no needle attached) into the ice bath. Upon introduction into the cold water, the gel formed a vertical “fiber” that tended to stay suspended in the water, as shown in FIG. 6 a. The appearance of the gel tended to change from fairly transparent to a whitish color, as shown in FIG. 6 b. This was speculated to be due to conversion of the silk I egel conformation to β-sheet. Future materials characterization will confirm this.
Example 8 Drawing of Egel Fiber from Ice Water Bath I
Using the same experimental setup from Example 7, the liquid silk “fiber” that had been quenched in the ice bath was then drawn out of the bath. As before, the fiber could be drawn to a fairly long length. For this experiment, only one fiber was drawn to a length of about 10 inches. The fiber was as sticky as the prior fibers, but more prone to failure during drawing. This fiber appeared to be much more homogeneous, with a fairly smooth surface and consistent cross-sectional geometry. After hanging overnight from a lab bench shelf, the fiber was found to have become smaller in diameter, but overall was much tougher than the prior fibers: It was not as brittle and could withstand considerable tensile loading. The fiber appeared to be fairly transparent, which provides promise that such fibers could be used to transmit light.
Example 9 Tests of Light-Carrying Capability of Drawn Silk Egel Fiber
Drawn silk egel fibers appear to be fairly transparent, and may be manufactured and used to transmit light. A simple experimental apparatus was built, as shown in FIG. 7 a in which a manual x-y stage was mounted vertically to an aluminum base. A presentation-style laser pointer was held firmly to the stage. A fiber holder was formed using machinable wax. A very small hole was drilled in the wax to snugly hold an egel fiber, as shown in FIG. 7 b. The results of the tests, shown in FIG. 8 a, laser light was carried through a fiber and projected onto a surface from the fiber end. The figure shows a second light patch above the fiber, which represents the direct transmission of light through the fiber holder hole. FIG. 8 b demonstrates the ability of a fiber to transmit light around a bend. Adjustments assured that the images are not due to light reflection on the outside of the fibers.
Example 10 Drawing of Egel Fiber from Ice Water Bath II
Silk egel fibers were drawn from an ice bath after undergoing one heating (60° C.) and quenching (<0° C.) cycle. FIG. 9 shows egel being formed on 3 platinum electrodes in a shortened Falcon tube. As shown, only one negative electrode is necessary. As in Example 7, the silk egel was placed in a 10 ml plastic syringe and heated to above 60° C. with a heat gun set to medium. The egel was extruded through the needle end of the syringe (no needle attached) into an ice bath, as shown in FIG. 10 a. As before, the egel material would tend to form a vertical underwater “fiber” that would stay suspended in the water. An insulated wire was used to draw this “fiber” out of the ice bath into ambient air. FIG. 10 b shows a fiber immediately after being drawn. FIG. 10 c shows a fiber tensioned between two insulated wires after about 30 min of air drying. Note that the beads that appear initially on the drawn fiber tend to dissipate with drying. Pulling on the fiber shows the fiber to be impressively strong for its diameter. In addition, the fibers drawn from the ice bath are quite tough after drying. FIG. 11 shows a stereo microscope image of one of the silk egel fibers that was drawn from the ice water bath. The bifurcations are likely water beads (FIG. 10 b) that have dried. In the straight segments between the bifurcations, the fiber diameter is approximately 100 μm. The fiber is noticeably transparent when viewed under a microscope.
Example 11 Exploration of Super-Contraction and Small-Contraction Cycling
Literature suggests that spider dragline silk exhibits two distinctly different contraction responses in the presence of humidity. Dragline silk, a type of silk used to make webs, exhibits supercontraction in high humidity. The contraction, which can reach 50%, is thought to be nature's way of refreshing the web; morning dew will tighten the web. Recent research has shown that spider silk also undergoes a cyclic relaxation-contraction response to smaller changes in humidity. In this case, drying of silk caused stress and contraction, albeit at a much lower magnitude, and an increase in humidity causes elongation as relaxation is induced. Blackledge et al., How super is supercontraction? Persistent versus cyclic responses to humidity in spider dragline silk, 212 J. Experimental Bio. 1981-89 (2009).
This experiment and subsequent experiments were executed to investigate the ability of drawn egel fibers to exhibit both supercontraction and cyclical contraction/expansion. A Fisher Scientific hot plate (FIG. 9 c) was used to heat milli-Q water to about 60° C. Egel was formed using three platinum electrodes, as shown in FIGS. 9 a and 9 b. The platinum electrodes with the egel attached were submerged in the heated water bath, as shown in FIG. 12, seemingly causing the silk from the egel to separate from the gel's water content. When FIGS. 12 c and 12 d are studied closely, the silk material can be seen falling into a pool at the base of the beaker. Over a span of 5 min, most of the egel is removed from the electrodes. As the bubbles trapped within the gel are freed, they rise to the water surface. After removal of the beaker from the hot plate, fibers were drawn from the beaker by dragging an insulated wire through the silk pool at the base of the beaker (FIG. 13). Drawn fibers were dried in air by suspending the insulated wires from elevated shelving.
A 93.31 mm-long dried fiber was suspended in an empty 4 L beaker, with a 133 mg weight attached, as shown in FIG. 14 a. Boiling water was poured into the beaker and the fiber length was monitored with a camera (FIGS. 14 b-e). Significant elongation was seen after the fiber was exposed to the hot steam for about 20 sec. The total elongation exceeded approximately 35% of the original fiber length. After removal of humidity generated by the steam, the fiber contracted almost completely to its original length of about 93 mm.
A custom-designed and-built humidity chamber was fabricated for studying small-contraction cycling. Using ⅛″ acrylic, a 24×24×24 in3 chamber was fashioned. A Kaz Model V5100NS Ultrasonic Humidifier, shown in FIG. 15, was positioned inside the chamber, with a capability of bringing the internal humidity from room ambient relative humidity (around 44%) to about 95%. Because the humidifier uses ultrasonic energy to create a humid mist, the chamber temperature does not change appreciably from ambient temperature (around 26° C. on this day of testing). A Lufft C200 hand-held humidity/temperature measurement device was used to monitor chamber conditions. In this experiment, a drawn egel fiber (a quenched fiber) was suspended from the top of the chamber, with a 33 mg weight attached to the end with laboratory-grade tape. The initial fiber length was about 15 cm, as seen in FIG. 16 a. With the chamber closed, the ultrasonic humidifier was turned on. In a span of about 2 min, the relative humidity inside the chamber increased from ambient humidity (around 44%) to about 95%. As shown in FIG. 16 b (horizontal lines added for clarity), while the humidity increased to about 95%, the drawn egel fiber elongated approximately 1.2 cm, which is about an 8% increase from the original length. After turning off the ultrasonic humidifier and opening the front panel of the chamber, the humidity dropped back to ambient humidity. During the decrease of humidity, the drawn egel fiber contracted nearly to its original length. The total humidity cycle took place over a 4 min time span. The chamber temperature was fairly steady at about 26° C. It should be noted that while the overall elongation/contraction cycle occurred over a 50% relative humidity change, most of the motion was seen over a humidity range of between 82% and 95%, as shown in FIG. 17.
Example 12 Additional Experiment on Small-Contraction Cycling
Using the custom-designed humidity chamber described in Example 11, the contraction behavior of two fibers were compared. Both fibers were cut from the same virgin fiber than was drawn from hot egel (no quenching). The approximately 7.8 mm-long sample had a small piece of tape, with negligible weight, attached to the end to help with length measurement. The second, a 16.5 mm long drawn egel fiber, had a 33 mg piece of tape attached. Although the humidity was cycled from about 50% relative humidity to about 95%, only the drying cycle is shown in FIG. 18. As the humidity decreased, the fibers contracted in length. As shown in Table 1, the incremental amount that each fiber contracted was fairly close between the fibers, despite the disparity in original length. The incremental percentage contraction of the previously cycled fiber was much greater than for the virgin drawn egel fiber.
TABLE 1
Comparison of Fiber Contraction Behavior between
a virgin drawn egel fiber and a drawn fiber that
had previously undergone humidity cycling
Weighted Egel Fiber (33 mg) Unweighted Egel Fiber
Fiber Length Fiber Length
Length Change % Length Change %
Humidity [mm] [mm] Decrease [mm] [mm] Decrease
99.7% 16.4 7.8
86.3% 15.4 1.0 6.1% 7.0 .8 10.3%
71.8% 15.0 .4 2.6% 6.6 .4 5.7%
62.4% 14.8 .2 1.3% 6.3 .3 4.5%
Example 13 Tensile Testing of Drawn Egel Fibers
Tensile testing was performed on several drawn egel fibers and cocoon fiber to compare maximum tensile stress. An Instron 3366 tensile frame was used with a 10 N load cell. Tests were conducted under extension control with a 0.02 in/min extension rate. Fiber samples were mounted to cardboard tabs with super glue. The cardboard tabs were secured to the machine using pneumatic grips, as shown in FIG. 19. The measurement of fiber diameter was a challenge for these tensile tests. They were measured using a Vernier caliper which had a low precision for the small scale of the fibers. A microscope can also be used to determine fiber diameter. FIG. 20 shows the raw load-extension data for five fibers tested: (1) drawn egel fiber that had undergone a humidity cycle (with ultrasonic humidifier); (2) cocoon fiber that was pulled from a virgin silkworm cocoon; (3) another drawn egel fiber from the same cycled fiber as #1; (4) virgin drawn egel fiber that had not undergone a humidity cycle; and (5) drawn egel fiber that had undergone a heated steam cycle (generated with boiling water), as in example 11.
Results showed that the egel fibers were all significantly stiffer than the cocoon fiber. The fibers that had undergone humidity cycles with an ultrasonic humidifier exhibited unique load-extension response from the other two drawn egel samples: while all egel fibers exhibited an initially steep linear elastic response, the cycled fibers exhibited significant plastic strain after a peak load was reached. The virgin silk egel fiber and fiber that was cycled with hot steam both failed catastrophically after their peak load was reached. Table 2 shows the diameter and peak tensile stress for each fiber tested. In general, the smaller the fiber, the greater the tensile strength. This is consistent with published results from both cocoon silk and regenerated silk fibroin fibers and is likely due to heightened alignment that occurs with the draw-down of the fiber diameter. The drawn egel fiber that had undergone humidity cycling with heated steam was, by far, the strongest. It exhibited much higher strength than cocoon fiber.
TABLE 2
Comparison of Maximum Tensile Stress Between Drawn Egel Fibers
Max.
Estimated Tensile
Diameter Stress
Specimen # Type of Fiber [μm] [MPa]
1 drawn egel/ultrasonic humidity cycle 0.10 33.7
2 cocoon fiber 0.01 595.4
3 drawn egel/ultrasonic humidity cycle 0.04 117.3
4 virgin drawn egel fiber 0.04 69.6
5 drawn egel/hot steam cycle 0.01 1015.7
Example 14 Imaging of Drawn Silk Egel Fibers
Images of individual fibers were captured using a digital camera and stereo microscope, as shown in FIG. 21 a. FIG. 21 b shows images of three drawn egel fibers: a fiber that had undergone humidity cycles with an ultrasonic humidifier; a virgin drawn egel fiber; and a fiber that had undergone quenching in an ice bath before drawing. Given all fibers have been drawn by hand, the fiber diameters vary and there are bifurcations, or bulges, that can be retained by the fiber. All of the fibers appear to be transparent, thus light can be transmitted through them.
Example 15 SEM Images of Drawn Silk Egel Fibers
SEM images of several drawn egel fibers were taken, as shown in FIG. 22. Overall, the fibers had a fairly smooth surface, with two distinct features. As seen in both Figures, the fiber appears to be folded as if it were two fibers paired together. It is one fiber, but possibly drying rate or drawing instability may be causing this interesting folding feature. As shown in FIG. 22 a, the fiber appeared to have some microcracks that suggest some damage was experienced, possibly when the fiber was bent with a small bend radius. Positive results from quenching indicates that fibers can be produced that are less brittle, which would possibly prevent the microcrack formation and lead to improved strength. This would also allow the fiber to be bent with smaller radii.

Claims (25)

The invention claimed is:
1. A method of producing a silk fiber comprising: providing a silk fibroin gel comprising silk protein in a meta-stable silk I conformation; converting the silk fibroin gel to a viscous silk liquid;
drawing a silk fiber from the viscous silk liquid.
2. The method of claim 1, wherein converting the silk fibroin gel to the viscous silk liquid comprises quenching the silk fibroin gel in water.
3. The method of claim 2, wherein the water has a temperature at or below 0° C.
4. The method of claim 2, wherein the water has a temperature in the range from 40° C. to 80° C.
5. The method of claim 2, wherein drawing the silk fiber is performed at a temperature ranging from 10° C. to 40° C.
6. The method of claim 2, wherein converting the silk fibroin gel to the viscous silk liquid further comprises heating the silk fibroin gel prior to the quenching step.
7. The method of claim 6, wherein the silk fibroin gel is heated to a temperature higher than the temperature of water used in the quenching step.
8. The method of claim 1, further comprising drying the silk fiber.
9. The method of claim 1, further comprising contracting the silk fiber.
10. The method of claim 9, wherein said contracting the silk fiber comprises reducing the ambient humidity to which the silk fiber is exposed.
11. The method of claim 1, further comprising expanding the silk fiber.
12. The method of claim 11, wherein said expanding the silk fiber comprises increasing the ambient humidity to which the silk fiber is exposed.
13. The method of claim 12, wherein the silk fiber is exposed to steam.
14. The method of claim 1, wherein the silk fibroin gel comprising the silk protein in the meta-stable silk I conformation is produced by applying an electric field to a silk fibroin solution.
15. The method of claim 1, wherein said converting the silk fibroin gel to the viscous silk liquid comprises heating the silk fibroin gel.
16. The method of claim 15, wherein the silk fibroin gel is heated to a temperature of about 60° C. to about 75° C.
17. The method of claim 16, wherein the silk fibroin gel is heated in water.
18. The method of claim 2, wherein the viscous silk liquid is quenched in water having a temperature selected from the group consisting of: at or below 0° C., in the range of about 10° C. to about 40° C., and in the range of about 40° C. to about 80° C.
19. The method of claim 1, further comprising subjecting the silk fiber to a post-processing treatment for changing solubility of the silk fiber.
20. The method of claim 19, further comprising processing the silk fiber with an alcohol treatment or water annealing treatment to generate a water-insoluble silk fiber.
21. The method of claim 1, further comprising incorporating at least one silk fiber into a composite.
22. The method of claim 21, wherein the composite comprises combining at least one silk fiber with one or more silk fibers or other fibers, one or more polymers, or other forms of silk material.
23. The method of claim 22, wherein the composite is a textile-based component or structure, a sensor, an analog to a muscle fiber, a tissue material, a photomechanical actuation, a fiber optic cable, an electro-optic fiber and a smart material.
24. The method of claim 1, wherein the silk fiber is a silk optical fiber, a silk waveguide, a silk multi-mode fiber, or a silk single mode fiber.
25. The method of claim 1, wherein the silk fiber further comprises an active agent.
US13/498,722 2009-09-28 2010-09-28 Methods of making drawn silk fibers Active 2032-06-15 US9074302B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/498,722 US9074302B2 (en) 2009-09-28 2010-09-28 Methods of making drawn silk fibers

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24632309P 2009-09-28 2009-09-28
US13/498,722 US9074302B2 (en) 2009-09-28 2010-09-28 Methods of making drawn silk fibers
PCT/US2010/050565 WO2011038401A2 (en) 2009-09-28 2010-09-28 Drawn silk egel fibers and methods of making same

Publications (2)

Publication Number Publication Date
US20120244143A1 US20120244143A1 (en) 2012-09-27
US9074302B2 true US9074302B2 (en) 2015-07-07

Family

ID=43796534

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/498,722 Active 2032-06-15 US9074302B2 (en) 2009-09-28 2010-09-28 Methods of making drawn silk fibers

Country Status (6)

Country Link
US (1) US9074302B2 (en)
EP (1) EP2483460B1 (en)
JP (1) JP2013506058A (en)
CA (1) CA2775706A1 (en)
IL (1) IL218883A0 (en)
WO (1) WO2011038401A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018119252A (en) * 2016-11-16 2018-08-02 アディダス アーゲー Clothing and shoe including spider silk
US10287728B2 (en) 2014-12-02 2019-05-14 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
WO2020033970A3 (en) * 2018-08-10 2020-03-19 Bolt Threads, Inc. Composition for a molded body
JP2020537064A (en) * 2017-10-09 2020-12-17 スピベル テクノロジーズ アクティエボラーグ Methods and devices for textile production
US11192982B2 (en) 2013-09-17 2021-12-07 Bolt Threads, Inc. Methods and compositions for synthesizing improved silk fibers
US11208736B2 (en) 2017-09-25 2021-12-28 Bolt Threads, Inc. Methods of generating highly-crystalline recombinant spider silk protein fibers
US11390988B2 (en) 2017-09-27 2022-07-19 Evolved By Nature, Inc. Silk coated fabrics and products and methods of preparing the same
US11447532B2 (en) 2016-09-14 2022-09-20 Bolt Threads, Inc. Long uniform recombinant protein fibers
US11512425B2 (en) 2015-07-14 2022-11-29 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902932B2 (en) 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
US7557367B2 (en) 2004-06-04 2009-07-07 The Board Of Trustees Of The University Of Illinois Stretchable semiconductor elements and stretchable electrical circuits
WO2010042653A1 (en) 2008-10-07 2010-04-15 Mc10, Inc. Catheter balloon having stretchable integrated circuitry and sensor array
US8886334B2 (en) 2008-10-07 2014-11-11 Mc10, Inc. Systems, methods, and devices using stretchable or flexible electronics for medical applications
US8389862B2 (en) 2008-10-07 2013-03-05 Mc10, Inc. Extremely stretchable electronics
US9204954B2 (en) 2008-12-15 2015-12-08 Allergan, Inc. Knitted scaffold with diagonal yarn
US9204953B2 (en) 2008-12-15 2015-12-08 Allergan, Inc. Biocompatible surgical scaffold with varying stretch
US9326840B2 (en) 2008-12-15 2016-05-03 Allergan, Inc. Prosthetic device and method of manufacturing the same
RU2015108720A (en) 2008-12-15 2015-08-10 Аллерган, Инк. KNITTED SURGICAL IMPLANTED NET
US9308070B2 (en) * 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US9723122B2 (en) 2009-10-01 2017-08-01 Mc10, Inc. Protective cases with integrated electronics
US9936574B2 (en) 2009-12-16 2018-04-03 The Board Of Trustees Of The University Of Illinois Waterproof stretchable optoelectronics
WO2011084450A1 (en) 2009-12-16 2011-07-14 The Board Of Trustees Of The University Of Illinois Electrophysiology in-vivo using conformal electronics
US10441185B2 (en) 2009-12-16 2019-10-15 The Board Of Trustees Of The University Of Illinois Flexible and stretchable electronic systems for epidermal electronics
CN104224171B (en) 2010-03-17 2017-06-09 伊利诺伊大学评议会 Implantable bio-medical instrument based on biological absorbable matrix
US9517357B2 (en) 2010-09-03 2016-12-13 Tufts University Plasmonic nanoparticle-doped silk materials
WO2012158709A1 (en) 2011-05-16 2012-11-22 The Board Of Trustees Of The University Of Illinois Thermally managed led arrays assembled by printing
EP2712491B1 (en) 2011-05-27 2019-12-04 Mc10, Inc. Flexible electronic structure
EP2713863B1 (en) 2011-06-03 2020-01-15 The Board of Trustees of the University of Illionis Conformable actively multiplexed high-density surface electrode array for brain interfacing
US9622779B2 (en) 2011-10-27 2017-04-18 DePuy Synthes Products, Inc. Method and devices for a sub-splenius / supra-levator scapulae surgical access technique
WO2013089867A2 (en) 2011-12-01 2013-06-20 The Board Of Trustees Of The University Of Illinois Transient devices designed to undergo programmable transformations
CN105283122B (en) 2012-03-30 2020-02-18 伊利诺伊大学评议会 Appendage mountable electronic device conformable to a surface
US9925301B2 (en) 2012-04-06 2018-03-27 Trustees Of Tufts College Methods of producing and using silk microfibers
US9171794B2 (en) 2012-10-09 2015-10-27 Mc10, Inc. Embedding thin chips in polymer
KR20210153142A (en) 2013-09-30 2021-12-16 실크 테라퓨틱스, 인코퍼레이티드 Silk protein fragment compositions and articles manufactured therefrom
US10071180B1 (en) 2014-05-28 2018-09-11 Verily Life Sciences Llc Devices and systems for an illuminated surgical suture
ES2534528B1 (en) * 2015-02-27 2016-02-02 Universidad De Murcia Silk fiber side light emission
JP2018524566A (en) 2015-06-01 2018-08-30 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ Alternative UV sensing method
AU2016270807A1 (en) 2015-06-01 2017-12-14 The Board Of Trustees Of The University Of Illinois Miniaturized electronic systems with wireless power and near-field communication capabilities
WO2016201183A1 (en) * 2015-06-10 2016-12-15 Riina Howard A Ecostructural bicycle/activity sfety helmet
US10925543B2 (en) 2015-11-11 2021-02-23 The Board Of Trustees Of The University Of Illinois Bioresorbable silicon electronics for transient implants
EP3594384A4 (en) * 2017-03-10 2020-12-09 Spiber Inc. Method and device for manufacturing protein fiber
JP6337252B1 (en) * 2017-03-10 2018-06-06 Spiber株式会社 High shrinkage artificial fibroin fiber, method for producing the same, and method for shrinking artificial fibroin fiber
JP2020097796A (en) * 2017-03-10 2020-06-25 Spiber株式会社 Artificial fibroin fiber
JP6807089B2 (en) * 2017-07-26 2021-01-06 Spiber株式会社 Modified fibroin
WO2019066053A1 (en) * 2017-09-29 2019-04-04 Spiber株式会社 Protein fiber production method, protein fiber production device, and protein fiber processing method
JP7237314B2 (en) * 2017-09-29 2023-03-13 Spiber株式会社 Method for producing protein fiber, device for producing protein fiber, and method for processing protein fiber
JP2021080573A (en) * 2018-01-31 2021-05-27 Spiber株式会社 Filamentary tow of protein filament and fabrication method thereof
JP2021167277A (en) * 2018-04-03 2021-10-21 Spiber株式会社 Artificial fibroin fiber
JP2021167470A (en) * 2018-04-03 2021-10-21 Spiber株式会社 High-shrinkage man-made fibroin fiber and its production method, and shrinkage method of man-made fibroin fiber
CN112534090B (en) * 2018-04-03 2023-07-11 丝芭博株式会社 High-shrinkage artificial fibroin staple yarn, method for producing same, and artificial fibroin staple yarn and method for shrinking same
CN112567083B (en) * 2018-04-03 2023-07-07 丝芭博株式会社 High-shrinkage artificial fibroin twisted yarn, method for producing same, and artificial fibroin twisted yarn and method for shrinking same
EP3919658A4 (en) * 2019-01-31 2023-06-07 Aderans Company Limited Fiber for artificial hairs, artificial hair, method for producing fiber for artificial hairs, and method for producing artificial hair
MX2022000463A (en) * 2019-07-12 2022-02-03 Bolt Threads Inc Recombinant spider silk extrudate formulations.
JP2023524421A (en) 2020-05-13 2023-06-12 オート・エコール・アルク Optical waveguide and method for manufacturing optical waveguide
CN112806664B (en) * 2021-01-26 2022-09-06 贵州怡家人生态科技有限公司 Big silkworm cap tearing equipment suitable for textile industry
CN114306756A (en) * 2021-12-03 2022-04-12 中国科学院上海微系统与信息技术研究所 Self-contraction fibroin tissue lifting material and preparation method thereof
CN115137009A (en) * 2022-07-12 2022-10-04 南昌大学 Self-assembly protein gel of globular protein under low-voltage electric field and method thereof

Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1989005A (en) 1929-12-23 1935-01-22 Ig Farbenindustrie Ag Solutions of fibroin
GB1182153A (en) 1966-05-20 1970-02-25 Ethicon Inc Silk Suture or Ligature.
JPS55139427A (en) 1979-04-17 1980-10-31 Kanebo Ltd Production of finely powdered silk fibroin
JPS56166235A (en) 1980-05-24 1981-12-21 Kanebo Ltd Hydrophilic porous body and its preparation
JPS60142259A (en) 1983-12-29 1985-07-27 Kanebo Ltd Immobilized antibody
JPS60259677A (en) 1984-05-31 1985-12-21 水島 繁三郎 Raw yarn, fabric and knitted fabric comprising animal protein adsorbed regeneration fiber and its production
US4798722A (en) 1986-11-12 1989-01-17 Zotos International, Inc. Permanent waving composition
US4820418A (en) 1987-02-03 1989-04-11 Agency Of Industrial Science & Technology Water-alcohol separating membrane and method for separation of water and alcohol by the use thereof
JPH01118544A (en) 1987-11-02 1989-05-11 Agency Of Ind Science & Technol Porous product of silk fibroin
EP0361391A2 (en) 1988-09-29 1990-04-04 Seiwa Kasei Co., Ltd. Permanent waving composition
US5047507A (en) 1988-01-05 1991-09-10 Research Corporation Technologies, Inc. Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen
JPH04263611A (en) 1991-02-16 1992-09-18 Pola Chem Ind Inc Water-insoluble solid fibroin formed article and its production
JPH05163132A (en) 1991-12-13 1993-06-29 Kanebo Ltd Skin cosmetic
US5252285A (en) 1992-01-27 1993-10-12 E. I. Du Pont De Nemours And Company Process for making silk fibroin fibers
US5290494A (en) 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
JPH06346314A (en) 1993-06-02 1994-12-20 Toyobo Co Ltd Regenerated silk fibroin yarn and its production
US5538735A (en) 1993-02-19 1996-07-23 Ahn; Sam S. Method of making a drug delivery system using hollow fibers
JPH08295697A (en) 1995-04-26 1996-11-12 Kanebo Ltd Production of aqueous solution of silk fibroin at high concentration
US5606019A (en) 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
JPH1036676A (en) 1996-07-26 1998-02-10 Kanebo Ltd Method for concentrating aqueous protein solution
US5728810A (en) 1990-04-20 1998-03-17 University Of Wyoming Spider silk protein
US5770193A (en) 1986-11-20 1998-06-23 Massachusetts Institute Of Technology Children's Medical Center Corporation Preparation of three-dimensional fibrous scaffold for attaching cells to produce vascularized tissue in vivo
WO1999001089A1 (en) 1997-07-01 1999-01-14 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
WO1999045964A1 (en) 1998-03-12 1999-09-16 Shearwater Polymers, Incorporated Poly(ethylene glycol) derivatives with proximal reactive groups
US5994099A (en) 1997-12-31 1999-11-30 The University Of Wyoming Extremely elastic spider silk protein and DNA coding therefor
US6106816A (en) 1990-06-20 2000-08-22 Chesebrough-Pond's Usa Co., Divison Of Concopo, Inc. Stable, pearly shampoo compositions containing non-volatile silicone
US6110590A (en) 1998-04-15 2000-08-29 The University Of Akron Synthetically spun silk nanofibers and a process for making the same
US6123819A (en) 1997-11-12 2000-09-26 Protiveris, Inc. Nanoelectrode arrays
JP2000273264A (en) 1999-03-23 2000-10-03 Natl Inst Of Sericultural & Entomological Science Biopolymer/polyallylamine complex and its production
US6175053B1 (en) 1997-06-18 2001-01-16 Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forrestry And Fisheries Wound dressing material containing silk fibroin and sericin as main component and method for preparing same
WO2001036531A1 (en) 1999-11-15 2001-05-25 Zaidan-Houjin Ueda Sen-I Kagaku Shinkoukai Molecularly composite polymeric material of fibroin/cellulose and process for producing the same
WO2001056626A1 (en) 2000-02-03 2001-08-09 Nexia Biotechnologies, Inc. Surgical sutures containing spider silk
US20020028243A1 (en) 1998-09-25 2002-03-07 Masters David B. Protein matrix materials, devices and methods of making and using thereof
WO2002072931A1 (en) 2001-03-14 2002-09-19 Japan As Represented By President Of Tokyo University Of Agriculture And Technology Method for producing fiber and film of silk and silk-like material
US20030007991A1 (en) 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
WO2003022909A1 (en) 2001-09-11 2003-03-20 Consorzio Per Gli Studi Universitari Method for the preparation of silk fibroin hydrogels
WO2003038033A2 (en) 2001-10-02 2003-05-08 Northwestern University Protein and peptide nanoarrays
JP2003192807A (en) 2001-12-28 2003-07-09 Japan Science & Technology Corp Silk protein film and method for producing the same
US6592623B1 (en) 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
WO2004000915A2 (en) 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof
US20040005363A1 (en) 2002-06-19 2004-01-08 National Institute Of Agrobiological Sciences Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers
JP2004068161A (en) 2001-03-14 2004-03-04 Tokyo Univ Of Agriculture & Technology Method for producing fiber, film and nonwoven fabric of silk and silky material and fiber, film or nonwoven fabric produced by the method
US20040097709A1 (en) 2000-10-02 2004-05-20 Ubaldo Armato Method for the preparation of a non-woven silk fibroin fabrics
WO2004041845A2 (en) 2002-11-01 2004-05-21 Trustees Of Tufts College Templated native silk smectic gels
US6815427B2 (en) 2000-10-24 2004-11-09 National Institute Of Agrobiological Sciences Sericin-containing material, process for producing the same method of using the same
WO2005012606A2 (en) 2003-04-10 2005-02-10 Tufts University Concentrated aqueous silk fibroin solution and use thereof
US6902932B2 (en) 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
US20050147681A1 (en) 2001-01-19 2005-07-07 Xuan Zhao Multi-arm block copolymers as drug delivery vehicles
WO2005123114A2 (en) 2004-06-11 2005-12-29 Trustees Of Tufts College Silk-based drug delivery system
US7041797B2 (en) 2001-10-31 2006-05-09 Spin'tec Engineering Gmbh Precursor silk feedstock for forming filaments
US7057023B2 (en) 2002-01-11 2006-06-06 Nexia Biotechnologies Inc. Methods and apparatus for spinning spider silk protein
KR100730367B1 (en) 2006-06-09 2007-06-19 한국에너지기술연구원 Method of manufacturing silk nano-fiber using electrospinning from waste silk and it's manufacture goods, and bio-composite materials using the silk nano-fiber and method of manufacturing the same
US20070212730A1 (en) 2005-04-20 2007-09-13 Trustees Of Tufts College Covalently immobilized protein gradients in three-dimensional porous scaffolds
US20080058400A1 (en) 2006-08-29 2008-03-06 Fujifilm Corporation Skin external preparation
WO2008052755A2 (en) 2006-10-30 2008-05-08 Spin'tec Engineering Gmbh Method and apparatus for the manufacture of a fibre
WO2008052775A2 (en) 2006-10-31 2008-05-08 Baseclick Gmbh Click chemistry for the production of reporter molecules
WO2008127405A2 (en) 2006-11-03 2008-10-23 Trustees Of Tufts College Microfluidic device with a cylindrical microchannel and a method for fabricating same
US20080280360A1 (en) 2004-10-12 2008-11-13 Trustees Of Tufts College Method for Producing Biomaterial Scaffolds
US20080293919A1 (en) 2005-01-14 2008-11-27 Kaplan David L Fibrous Protein Fusions and Use Thereof in the Formation of Advanced Organic/Inorganic Composite Materials
US20090171467A1 (en) 2005-08-17 2009-07-02 Oxford Biomaterials Ltd. Implantable cartilaginous tissue repair device
US20090202614A1 (en) 2005-08-02 2009-08-13 Trustees Of Tufts College Methods for stepwise deposition of silk fibroin coatings
US20090232963A1 (en) 2008-03-13 2009-09-17 Trustees Of Tufts College Diazonium salt modification of silk polymer
WO2009126689A2 (en) 2008-04-08 2009-10-15 Trustees Of Tufts College System and method for making biomaterial structures
US20090297588A1 (en) 2008-05-28 2009-12-03 Spin'tec Engineering Gmbh Antibiotic dressing for the treatment of infected wounds
WO2009156226A2 (en) 2008-06-25 2009-12-30 Spintec Engineering Gmbh A silk membrane for bone graft material and a method for manufacture thereof
US20100028451A1 (en) 2006-09-26 2010-02-04 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US20100046902A1 (en) 2006-11-03 2010-02-25 Trustees Of Tufts College Biopolymer photonic crystals and method of manufacturing the same
US20100063404A1 (en) 2006-11-03 2010-03-11 Trustees Of Tufts College Biopolymer optical waveguide and method of manufacturing the same
US20100070068A1 (en) 2006-11-03 2010-03-18 Trustees Of Tufts College Biopolymer sensor and method of manufacturing the same
US20100095827A1 (en) 2008-10-17 2010-04-22 Spintec Engineering Gmbh Apparatus and method for the manufacture of a silk mono-filament with a high tensile strength
US20100120116A1 (en) 2006-11-03 2010-05-13 Trustees Of Tufts College Nanopatterned biopolymer optical device and method of manufacturing the same
US7727575B2 (en) 2003-06-06 2010-06-01 Trustees Of Tufts College Method for forming inorganic coatings
WO2010060600A1 (en) 2008-11-27 2010-06-03 Kpss-Kao Professional Salon Services Gmbh Bleaching/highlighting composition
US20100178304A1 (en) 2007-05-29 2010-07-15 Trustees Of Tufts College Method for silk fibroin gelation using sonication
US20100191328A1 (en) 2007-02-27 2010-07-29 Trustees Of Tufts College Tissue-engineered silk organs
US20100249924A1 (en) 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
US20100292338A1 (en) 2009-05-15 2010-11-18 Spintec Engineering Gmbh Silk medical device with antimicrobial properties and a method of manufacture thereof
US7842780B2 (en) 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
US20110008436A1 (en) 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
WO2011006133A2 (en) 2009-07-10 2011-01-13 Trustees Of Tufts College Bioengineered silk protein-based nucleic acid delivery systems
US20110046686A1 (en) 2008-02-07 2011-02-24 Trustees Of Tufts College 3-dimensional silk hydroxyapatite compositions
US20110052695A1 (en) 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20110105402A1 (en) 2004-07-31 2011-05-05 Brainguard Co., Ltd. Silk Peptide For Improving Neuroprotective And Neurofunctional Effects And A Method Of Its Prepartion
US20110121485A1 (en) 2006-10-30 2011-05-26 Spintec Engineering Gmbh Method and apparatus for the manufacture of a fiber
US20110135697A1 (en) 2008-06-18 2011-06-09 Trustees Of Tufts College Edible holographic silk products
US20110152214A1 (en) 2008-05-15 2011-06-23 Trustees Of Tufts College Silk polymer-based adenosine release: therapeutic potential for epilepsy
US20110171239A1 (en) 2008-09-26 2011-07-14 Trustees Of Tufts College pH INDUCED SILK GELS AND USES THEREOF
US20110189292A1 (en) 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
US20110223153A1 (en) 2008-10-09 2011-09-15 Trustees Of Tufts College Modified silk films containing glycerol
US20120039986A1 (en) 2003-04-18 2012-02-16 The Trustees Of The University Of Pennsylvania Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
US20120052124A1 (en) 2009-03-04 2012-03-01 Trustees Of Tufts College Silk fibroin systems for antibiotic delivery
US20120070427A1 (en) 2009-06-01 2012-03-22 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
US20120121820A1 (en) 2007-11-05 2012-05-17 Trustees Of Boston University Fabrication of silk fibroin photonic structures by nanocontact imprinting
US20120123519A1 (en) 2007-08-10 2012-05-17 Massachusetts Institute Of Technology Tubular silk compositions and methods of use thereof
US20120171256A1 (en) 2009-07-14 2012-07-05 The University Of Massachusetts Foundation, Inc. Electrospun silk material systems for wound healing
US20120187591A1 (en) 2009-09-29 2012-07-26 Trustees Of Tufts College Silk nanospheres and microspheres and methods of making same
US20120231499A1 (en) 2010-03-11 2012-09-13 Sang Yup Lee High-molecular-weight recombinant silk or silk-like protein and micro- or nano-sized spider silk or silk-like fiber produced therefrom
US8293486B2 (en) 2009-07-21 2012-10-23 Trustees Of Tufts College Functionalization of silk material by avidin-biotin interaction
US20130172999A1 (en) 2010-06-09 2013-07-04 Trustees Of Tufts College Multilayered silk scaffolds for meniscus tissue engineering
US20130287742A1 (en) 2010-09-01 2013-10-31 Trustees Of Tufts College Silk fibroin and polyethylene glycol-based biomaterials
US20130338632A1 (en) 2010-10-19 2013-12-19 Trustees Of Tufts College Silk fibroin-based microneedles and methods of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06166850A (en) * 1992-02-13 1994-06-14 Marie Murase Method for solubilizing and molding cocoon silk, artificial organ made of cocoon silk, and medical element made of cocoon silk
JP3460128B2 (en) * 1994-01-14 2003-10-27 喜代一 松本 Manufacturing method of silk fibroin fiber
WO2001070973A1 (en) * 2000-03-24 2001-09-27 Japan As Represented By President Of Tokyo University Of Agriculture And Technology Precursors of silk-like materials, silk-like materials and processes for producing both

Patent Citations (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1989005A (en) 1929-12-23 1935-01-22 Ig Farbenindustrie Ag Solutions of fibroin
GB1182153A (en) 1966-05-20 1970-02-25 Ethicon Inc Silk Suture or Ligature.
JPS55139427A (en) 1979-04-17 1980-10-31 Kanebo Ltd Production of finely powdered silk fibroin
US4233212A (en) 1979-04-17 1980-11-11 Kanebo, Ltd. Process for producing a fine powder of silk fibroin
JPS5838449B2 (en) 1979-04-17 1983-08-23 カネボウ株式会社 Manufacturing method of finely powdered silk fiproin
JPS56166235A (en) 1980-05-24 1981-12-21 Kanebo Ltd Hydrophilic porous body and its preparation
JPS60142259A (en) 1983-12-29 1985-07-27 Kanebo Ltd Immobilized antibody
JPS60259677A (en) 1984-05-31 1985-12-21 水島 繁三郎 Raw yarn, fabric and knitted fabric comprising animal protein adsorbed regeneration fiber and its production
US4798722A (en) 1986-11-12 1989-01-17 Zotos International, Inc. Permanent waving composition
US5770193A (en) 1986-11-20 1998-06-23 Massachusetts Institute Of Technology Children's Medical Center Corporation Preparation of three-dimensional fibrous scaffold for attaching cells to produce vascularized tissue in vivo
US4820418A (en) 1987-02-03 1989-04-11 Agency Of Industrial Science & Technology Water-alcohol separating membrane and method for separation of water and alcohol by the use thereof
US5606019A (en) 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
JPH01118544A (en) 1987-11-02 1989-05-11 Agency Of Ind Science & Technol Porous product of silk fibroin
US5047507A (en) 1988-01-05 1991-09-10 Research Corporation Technologies, Inc. Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen
EP0361391A2 (en) 1988-09-29 1990-04-04 Seiwa Kasei Co., Ltd. Permanent waving composition
US5290494A (en) 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
US5728810A (en) 1990-04-20 1998-03-17 University Of Wyoming Spider silk protein
US6106816A (en) 1990-06-20 2000-08-22 Chesebrough-Pond's Usa Co., Divison Of Concopo, Inc. Stable, pearly shampoo compositions containing non-volatile silicone
JPH04263611A (en) 1991-02-16 1992-09-18 Pola Chem Ind Inc Water-insoluble solid fibroin formed article and its production
JPH05163132A (en) 1991-12-13 1993-06-29 Kanebo Ltd Skin cosmetic
US5252285A (en) 1992-01-27 1993-10-12 E. I. Du Pont De Nemours And Company Process for making silk fibroin fibers
US5538735A (en) 1993-02-19 1996-07-23 Ahn; Sam S. Method of making a drug delivery system using hollow fibers
JPH06346314A (en) 1993-06-02 1994-12-20 Toyobo Co Ltd Regenerated silk fibroin yarn and its production
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
JPH08295697A (en) 1995-04-26 1996-11-12 Kanebo Ltd Production of aqueous solution of silk fibroin at high concentration
JPH1036676A (en) 1996-07-26 1998-02-10 Kanebo Ltd Method for concentrating aqueous protein solution
US6175053B1 (en) 1997-06-18 2001-01-16 Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forrestry And Fisheries Wound dressing material containing silk fibroin and sericin as main component and method for preparing same
WO1999001089A1 (en) 1997-07-01 1999-01-14 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US6123819A (en) 1997-11-12 2000-09-26 Protiveris, Inc. Nanoelectrode arrays
US5994099A (en) 1997-12-31 1999-11-30 The University Of Wyoming Extremely elastic spider silk protein and DNA coding therefor
WO1999045964A1 (en) 1998-03-12 1999-09-16 Shearwater Polymers, Incorporated Poly(ethylene glycol) derivatives with proximal reactive groups
US6110590A (en) 1998-04-15 2000-08-29 The University Of Akron Synthetically spun silk nanofibers and a process for making the same
US20020028243A1 (en) 1998-09-25 2002-03-07 Masters David B. Protein matrix materials, devices and methods of making and using thereof
US20030007991A1 (en) 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
JP2000273264A (en) 1999-03-23 2000-10-03 Natl Inst Of Sericultural & Entomological Science Biopolymer/polyallylamine complex and its production
US6592623B1 (en) 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
WO2001036531A1 (en) 1999-11-15 2001-05-25 Zaidan-Houjin Ueda Sen-I Kagaku Shinkoukai Molecularly composite polymeric material of fibroin/cellulose and process for producing the same
WO2001056626A1 (en) 2000-02-03 2001-08-09 Nexia Biotechnologies, Inc. Surgical sutures containing spider silk
US20040097709A1 (en) 2000-10-02 2004-05-20 Ubaldo Armato Method for the preparation of a non-woven silk fibroin fabrics
US7285637B2 (en) 2000-10-02 2007-10-23 Consorzio Per Gli Studi Universitari Method for the preparation of a non-woven silk fibroin fabrics
US6815427B2 (en) 2000-10-24 2004-11-09 National Institute Of Agrobiological Sciences Sericin-containing material, process for producing the same method of using the same
US20050147681A1 (en) 2001-01-19 2005-07-07 Xuan Zhao Multi-arm block copolymers as drug delivery vehicles
EP1277857A1 (en) 2001-03-14 2003-01-22 Japan as represented by President of Tokyo University of Agriculture and Technology Method for producing fiber and film of silk and silk-like material
US20030183978A1 (en) 2001-03-14 2003-10-02 Tetsuo Asakura Method of producing fiber and film of silk and silk-like material
CA2405850A1 (en) 2001-03-14 2002-10-10 Tetsuo Asakura Method for producing fiber and film of silk and silk-like material
JP2004068161A (en) 2001-03-14 2004-03-04 Tokyo Univ Of Agriculture & Technology Method for producing fiber, film and nonwoven fabric of silk and silky material and fiber, film or nonwoven fabric produced by the method
WO2002072931A1 (en) 2001-03-14 2002-09-19 Japan As Represented By President Of Tokyo University Of Agriculture And Technology Method for producing fiber and film of silk and silk-like material
WO2003022909A1 (en) 2001-09-11 2003-03-20 Consorzio Per Gli Studi Universitari Method for the preparation of silk fibroin hydrogels
US20040266992A1 (en) 2001-09-11 2004-12-30 Claudio Migliaresi Method for the preparation of silk fibron hydrogels
WO2003038033A2 (en) 2001-10-02 2003-05-08 Northwestern University Protein and peptide nanoarrays
US7041797B2 (en) 2001-10-31 2006-05-09 Spin'tec Engineering Gmbh Precursor silk feedstock for forming filaments
EP1440088B1 (en) 2001-10-31 2008-05-07 Spin'tec Engineering GmbH Precursor silk feedstock for forming filaments
US6902932B2 (en) 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
JP2003192807A (en) 2001-12-28 2003-07-09 Japan Science & Technology Corp Silk protein film and method for producing the same
US7057023B2 (en) 2002-01-11 2006-06-06 Nexia Biotechnologies Inc. Methods and apparatus for spinning spider silk protein
US20040005363A1 (en) 2002-06-19 2004-01-08 National Institute Of Agrobiological Sciences Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers
US7674882B2 (en) 2002-06-24 2010-03-09 Trustees Of Tufts College Silk biomaterials and methods of use thereof
US20050260706A1 (en) 2002-06-24 2005-11-24 Tufts University Silk biomaterials and methods of use thereof
US8071722B2 (en) 2002-06-24 2011-12-06 Trustees Of Tufts College Silk biomaterials and methods of use thereof
WO2004000915A2 (en) 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof
US20100196447A1 (en) 2002-06-24 2010-08-05 Trustees Of Tufts College Silk biomaterials and methods of use thereof
WO2004041845A2 (en) 2002-11-01 2004-05-21 Trustees Of Tufts College Templated native silk smectic gels
US7842780B2 (en) 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
US20130158131A1 (en) 2003-01-07 2013-06-20 Massachusetts Institute Of Technology Silk fibroin materials and use thereof
US8361617B2 (en) 2003-01-07 2013-01-29 Trustees Of Tufts College Silk fibroin materials and use thereof
US8614293B2 (en) 2003-04-10 2013-12-24 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US20070187862A1 (en) 2003-04-10 2007-08-16 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
WO2005012606A2 (en) 2003-04-10 2005-02-10 Tufts University Concentrated aqueous silk fibroin solution and use thereof
US20130165004A1 (en) 2003-04-10 2013-06-27 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US20130190222A1 (en) 2003-04-10 2013-07-25 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US20100055438A1 (en) 2003-04-10 2010-03-04 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US20090234026A1 (en) 2003-04-10 2009-09-17 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US7635755B2 (en) 2003-04-10 2009-12-22 Trustees Of Tufts College Concentrated aqueous silk fibroin solution and use thereof
US20120039986A1 (en) 2003-04-18 2012-02-16 The Trustees Of The University Of Pennsylvania Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
US20130177608A1 (en) 2003-06-06 2013-07-11 Trustees Of Tufts College Method for forming inorganic coatings
US20100203226A1 (en) 2003-06-06 2010-08-12 Trustees Of Tufts College Method for forming inorganic coatings
US7727575B2 (en) 2003-06-06 2010-06-01 Trustees Of Tufts College Method for forming inorganic coatings
US20130195831A1 (en) 2004-06-11 2013-08-01 Eidgenossisches Technische Hochschule (The Swiss Federal Institute of Technology) Silk-based drug delivery system
US8530625B2 (en) 2004-06-11 2013-09-10 Trustees Of Tufts College Silk-based drug delivery system
US20130177611A1 (en) 2004-06-11 2013-07-11 Eidgenossisches Technische Hochschule (The Swiss Federal Institute of Technology) Silk-based drug delivery system
US8178656B2 (en) 2004-06-11 2012-05-15 Trustees Of Tufts College Silk-based drug delivery system
US20080085272A1 (en) 2004-06-11 2008-04-10 Trustees Of Tufts College Silk-Based Drug Delivery System
WO2005123114A2 (en) 2004-06-11 2005-12-29 Trustees Of Tufts College Silk-based drug delivery system
US20110105402A1 (en) 2004-07-31 2011-05-05 Brainguard Co., Ltd. Silk Peptide For Improving Neuroprotective And Neurofunctional Effects And A Method Of Its Prepartion
US20080280360A1 (en) 2004-10-12 2008-11-13 Trustees Of Tufts College Method for Producing Biomaterial Scaffolds
US8129141B2 (en) 2005-01-14 2012-03-06 Trustees Of Tufts College Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
US8501437B2 (en) 2005-01-14 2013-08-06 Trustees Of Tufts College Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
US7960509B2 (en) 2005-01-14 2011-06-14 Trustees Of Tufts College Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
US20080293919A1 (en) 2005-01-14 2008-11-27 Kaplan David L Fibrous Protein Fusions and Use Thereof in the Formation of Advanced Organic/Inorganic Composite Materials
US20130230491A1 (en) 2005-04-20 2013-09-05 Massachusetts Institute Of Technology Covalently immobilized protein gradients in three-dimensional porous scaffolds
US20070212730A1 (en) 2005-04-20 2007-09-13 Trustees Of Tufts College Covalently immobilized protein gradients in three-dimensional porous scaffolds
US8354501B2 (en) 2005-08-02 2013-01-15 Trustees Of Tufts College Methods for stepwise deposition of silk fibroin coatings
US20130287835A1 (en) 2005-08-02 2013-10-31 Trustees Of Tufts College Methods for stepwise deposition of silk fibroin coatings
US20090202614A1 (en) 2005-08-02 2009-08-13 Trustees Of Tufts College Methods for stepwise deposition of silk fibroin coatings
US20130156844A1 (en) 2005-08-02 2013-06-20 Trustees Of Tufts College Methods for stepwise deposition of silk fibroin coatings
US20090171467A1 (en) 2005-08-17 2009-07-02 Oxford Biomaterials Ltd. Implantable cartilaginous tissue repair device
KR100730367B1 (en) 2006-06-09 2007-06-19 한국에너지기술연구원 Method of manufacturing silk nano-fiber using electrospinning from waste silk and it's manufacture goods, and bio-composite materials using the silk nano-fiber and method of manufacturing the same
US20080058400A1 (en) 2006-08-29 2008-03-06 Fujifilm Corporation Skin external preparation
US20130171260A1 (en) 2006-09-26 2013-07-04 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US20100028451A1 (en) 2006-09-26 2010-02-04 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US20130243866A1 (en) 2006-09-26 2013-09-19 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US20110121485A1 (en) 2006-10-30 2011-05-26 Spintec Engineering Gmbh Method and apparatus for the manufacture of a fiber
WO2008052755A2 (en) 2006-10-30 2008-05-08 Spin'tec Engineering Gmbh Method and apparatus for the manufacture of a fibre
WO2008052775A2 (en) 2006-10-31 2008-05-08 Baseclick Gmbh Click chemistry for the production of reporter molecules
US20100063404A1 (en) 2006-11-03 2010-03-11 Trustees Of Tufts College Biopolymer optical waveguide and method of manufacturing the same
WO2008127405A2 (en) 2006-11-03 2008-10-23 Trustees Of Tufts College Microfluidic device with a cylindrical microchannel and a method for fabricating same
US20100096763A1 (en) 2006-11-03 2010-04-22 Trustees Of Tufts College Biopolymer optofluidic device and method of manufacturing the same
US20100046902A1 (en) 2006-11-03 2010-02-25 Trustees Of Tufts College Biopolymer photonic crystals and method of manufacturing the same
US20100120116A1 (en) 2006-11-03 2010-05-13 Trustees Of Tufts College Nanopatterned biopolymer optical device and method of manufacturing the same
US20100068740A1 (en) 2006-11-03 2010-03-18 Trustees Of Tufts College Microfluidic device with a cylindrical microchannel and a method for fabricating same
US20100070068A1 (en) 2006-11-03 2010-03-18 Trustees Of Tufts College Biopolymer sensor and method of manufacturing the same
US20100065784A1 (en) 2006-11-03 2010-03-18 Trustees Of Tufts College Electroactive biopolymer optical and electro-optical devices and method of manufacturing the same
US20100191328A1 (en) 2007-02-27 2010-07-29 Trustees Of Tufts College Tissue-engineered silk organs
US20130060008A1 (en) 2007-05-29 2013-03-07 Trustees Of Tufts College Method for silk fibroin gelation using sonication
US20100178304A1 (en) 2007-05-29 2010-07-15 Trustees Of Tufts College Method for silk fibroin gelation using sonication
US8187616B2 (en) 2007-05-29 2012-05-29 Trustees Of Tufts College Method for silk fibroin gelation using sonication
US20120123519A1 (en) 2007-08-10 2012-05-17 Massachusetts Institute Of Technology Tubular silk compositions and methods of use thereof
US20120121820A1 (en) 2007-11-05 2012-05-17 Trustees Of Boston University Fabrication of silk fibroin photonic structures by nanocontact imprinting
US20110046686A1 (en) 2008-02-07 2011-02-24 Trustees Of Tufts College 3-dimensional silk hydroxyapatite compositions
US20120252120A1 (en) 2008-03-13 2012-10-04 Trustees Of Tufts College Diazonium salt modification of silk polymer
US20090232963A1 (en) 2008-03-13 2009-09-17 Trustees Of Tufts College Diazonium salt modification of silk polymer
US8206774B2 (en) 2008-03-13 2012-06-26 Trustees Of Tufts College Diazonium salt modification of silk polymer
WO2009126689A2 (en) 2008-04-08 2009-10-15 Trustees Of Tufts College System and method for making biomaterial structures
US20110076384A1 (en) 2008-04-08 2011-03-31 Trustees Of Tufts College System and method for making biomaterial structures
US20110152214A1 (en) 2008-05-15 2011-06-23 Trustees Of Tufts College Silk polymer-based adenosine release: therapeutic potential for epilepsy
WO2009153140A2 (en) 2008-05-28 2009-12-23 Spintec Engineering Gmbh Antibiotic dressing for the treatment of infected wounds
US20090297588A1 (en) 2008-05-28 2009-12-03 Spin'tec Engineering Gmbh Antibiotic dressing for the treatment of infected wounds
US20110135697A1 (en) 2008-06-18 2011-06-09 Trustees Of Tufts College Edible holographic silk products
WO2009156226A2 (en) 2008-06-25 2009-12-30 Spintec Engineering Gmbh A silk membrane for bone graft material and a method for manufacture thereof
US8501172B2 (en) 2008-09-26 2013-08-06 Trustees Of Tufts College pH-induced silk gels and uses thereof
US20110171239A1 (en) 2008-09-26 2011-07-14 Trustees Of Tufts College pH INDUCED SILK GELS AND USES THEREOF
US20110223153A1 (en) 2008-10-09 2011-09-15 Trustees Of Tufts College Modified silk films containing glycerol
US20100095827A1 (en) 2008-10-17 2010-04-22 Spintec Engineering Gmbh Apparatus and method for the manufacture of a silk mono-filament with a high tensile strength
WO2010060600A1 (en) 2008-11-27 2010-06-03 Kpss-Kao Professional Salon Services Gmbh Bleaching/highlighting composition
US20120052124A1 (en) 2009-03-04 2012-03-01 Trustees Of Tufts College Silk fibroin systems for antibiotic delivery
US20100249924A1 (en) 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
US20120207837A1 (en) 2009-03-27 2012-08-16 Allergan, Inc. Bioerodible matrix for tissue involvement
US20120172317A1 (en) 2009-04-20 2012-07-05 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20110008436A1 (en) 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20120265297A1 (en) 2009-04-20 2012-10-18 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US8288347B2 (en) 2009-04-20 2012-10-16 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
US20110189292A1 (en) 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
US8420077B2 (en) 2009-04-20 2013-04-16 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20120171265A1 (en) 2009-04-20 2012-07-05 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20110008437A1 (en) 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110052695A1 (en) 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20120172985A1 (en) 2009-04-20 2012-07-05 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20130172995A1 (en) 2009-04-20 2013-07-04 Allergan, Inc. Silk fibroin hydrogels and uses thereof
US20110008406A1 (en) 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110020409A1 (en) 2009-04-20 2011-01-27 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110014287A1 (en) 2009-04-20 2011-01-20 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20100292338A1 (en) 2009-05-15 2010-11-18 Spintec Engineering Gmbh Silk medical device with antimicrobial properties and a method of manufacture thereof
US20120070427A1 (en) 2009-06-01 2012-03-22 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
WO2011006133A2 (en) 2009-07-10 2011-01-13 Trustees Of Tufts College Bioengineered silk protein-based nucleic acid delivery systems
US20120171770A1 (en) 2009-07-10 2012-07-05 Trustees Of Tufts College Bioengineered silk protein-based nucleic acid delivery systems
US20120171256A1 (en) 2009-07-14 2012-07-05 The University Of Massachusetts Foundation, Inc. Electrospun silk material systems for wound healing
US8293486B2 (en) 2009-07-21 2012-10-23 Trustees Of Tufts College Functionalization of silk material by avidin-biotin interaction
US20120187591A1 (en) 2009-09-29 2012-07-26 Trustees Of Tufts College Silk nanospheres and microspheres and methods of making same
US20120231499A1 (en) 2010-03-11 2012-09-13 Sang Yup Lee High-molecular-weight recombinant silk or silk-like protein and micro- or nano-sized spider silk or silk-like fiber produced therefrom
US20130172999A1 (en) 2010-06-09 2013-07-04 Trustees Of Tufts College Multilayered silk scaffolds for meniscus tissue engineering
US20130287742A1 (en) 2010-09-01 2013-10-31 Trustees Of Tufts College Silk fibroin and polyethylene glycol-based biomaterials
US20130338632A1 (en) 2010-10-19 2013-12-19 Trustees Of Tufts College Silk fibroin-based microneedles and methods of making the same

Non-Patent Citations (90)

* Cited by examiner, † Cited by third party
Title
Agarwal et al., Journal of Applied Polymer Science, 63(3):401-410 (1997). "Effect of Moisture Absorption on the Thermal Properties of Bombyx mori Silk Fibroin Films."
Altman et al., Biomaterials, 23:4131-4141 (2002). "Silk matrix for tissue engineered anterior cruciate ligaments.".
Altman et al., Biomaterials, 24:401-416 (2003). "Silk-based biomaterials.".
Ando et al, Reports on Progress in Polymer Physics in Japan, XXIII:775-778 (1980). "Piezoelectric and Related properties of Hydrated Silk Fibroin.".
Asakura et al., Biotechnology and Bioengineering, 35:511-517 (1990). An ESR Study of Spin-Labeled Silk Fibroin Membranes and Spin-Labeled Glucose Oxidase Immobilized in Silk Fibroin Membranes.
Asakura et al., Macromolecules, 17:1075-1081 (1984). NMR of silk fibroin 2. 13C NMR study of the chain dynamics and solution structure of Bombyx mori silk fibroin.
Asakura et al., Macromolecules, 18:1841-1845 (1985). "Conformation Characterization of Bombyx Mori Silk Fibroin in the Solid State by High-Frequency 13C Cross Polarization-Magic Angle Spinning NMR, X-ray Diffraction, and Infrared Spectroscopy.".
Bini et al., J. Mol. Biol., 335:27-40 (2004). "Mapping Domain Structures in Silks from Insects and Spiders Related to Protein Assembly.".
Cai et al., Int. J. Mol. Sci., 11:3529-3539 (2010). "Fabrication of Chitosan/Silk Fibroin Composite Nanofibers for Wound-dressing Applications.".
Chao et al., J Biomed Mater Res B Appl Biomater., 95(1):84-90 Author Manuscript (2010). "Silk hydrogel for cartilage tissue engineering.".
Chen et al., Biomacromolecules, 3:644-648 (2002). "Rheological Characterization of Nephila Spidroin Solution."
Chen et al., Food Research International, 44:1468-1475 (2011). "Improvement of physicochemical stabilities of emulsions containing oil droplets coated by non-globular protein-beet pectin complex membranes."
Chen et al., J Appl Polymer Sci, 65:2257-2262 (1997). "pH sensitivity and ion sensitivity of hydrogels based on complex-forming chitosan/silk fibroin interpenetrating polymer network.".
Chen et al., J Appl Polymer Sci, 73:975-980 (1999). "Separation of alcohol-water mixture by pervaporation through a novel natural polymer blend membrane-chitosan/silk fibroin blend membrane-chitosan / silk fibroin blend membrane."
Chen et al., J Biomed Mater Res, 67A:559-570 (2003). "Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers."
Chen et al., Proteins: Structure, Function, and Bioinformatics, 68:223-231 (2007). "Conformation transition kinetics of Bombyx mori silk protein."
Demura et al., Biosensors, 4:361-372 (1989). "Immobilization of biocatalysts with Bombyx mori silk fibroin by several kinds of physical treatment and its application to glucose sensors."
Demura et al., J Membrane Science, 59:39-52 (1991). "Porous membrane of Bombyx mori silk fibroin: structure characterization, physical properties and application to glucose oxidase immobilization."
Derwent Record, Abstract of JP 08295697 A2 "Production of aqueous solution of silk fibroin at high concentration." Nov. 12, 1996.
Doshi et al. J Electrostatics, 35:151-160 (1995). "Electrospinning process and applications of electrospun fibers."
Dyakonov et al., Journal of Drug Delivery, Article 490514 (2012). "Design and Characterization of a Silk-Fibroin-Based Drug Delivery Platform Using Naproxen as a Model Drug."
Freddi et al., J Appl Polymer Sci, 56:1537-1545 (1995). "Silk fibroin/cellulose blend films: preparation, structure, and physical properties."
Furst et al., Ann Thorac Surg, 79:1522-1529 (2005). "Release of Glutaraldehyde From an Albumin-Glutaraldehyde Tissue Adhesive Causes Significant In Vitro and In Vivo Toxicity."
Gill et al., Urology, 65:463-466 (2005). "Improved Hemostasis During Laparoscopic Partial Nephrectomy Using Gelatin Matrix Thrombin Sealant."
Ha et al., Biomacromolecules, 6(3):1722-1731 (2005). "Structural studies of Bombyx mori silk fibroin during regeneration from solutions and wet fiber spinning."
Hijirida et al., Biophysical Journal, 71:3442-3447 (1996). "13C NMR of Nephila clavipes major ampullate silk gland."
Hinman et al., TIBTECH, 18:374-379 (2000). "Synthetic spider silk: a modular fiber."
Hofmann et al., Journal of Controlled Release, 111:219-227 (2006). "Silk fibroin as an organic polymer for controlled drug delivery."
Horan et al., Biomaterials, 26:3385-3393 (2005). "In vitro degradation of silk fibroin."
Hu et al., Biomacromolecules, 12:1686-1696 (2011). "Regulation of Silk Material Structure by Temperature-Controlled Water Vapor Annealing."
Huang et al., J Biomater Sci Polymer Edn, 12(9):979-993 (2001). "Engineered collagen-PEO nanofibers and fabrics."
Huang et al., Macromolecules, 33:2989-2997 (2000). "Generation of synthetic elastin-mimetic small diameter fibers and fiber networks."
International Search Report for PCT/US2010/050565, 3 pages (Jun. 29, 2011).
Jang et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109:831-836 (2010). "Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich fibrin and silk fibroin powder combination graft."
Jenkins et al., Surgery, 20:124-132 (1946). "Clinical and Experimental Observations on the Use of Gelatin Sponge or Foam."
Jiang et al., Materials Letters, 60:919-925 (2006). "Tensile behavior and morphology of differently degummed silkworm (Bombyx mori) cocoon silk fibres."
Jin et al., Adv. Funct. Mater., 15:1241-1247 (2005). "Water-Stable Silk Films with Reduced beta-Sheet Content."
Jin et al., Adv. Funct. Mater., 15:1241-1247 (2005). "Water-Stable Silk Films with Reduced β-Sheet Content."
Jin et al., Biomacromolecules, 3:1233-1239 (2002). "Electrospinning Bombyx mori silk with poly(ethylene oxide)."
Jin et al., Nature, 424:1057-1061 (2003). "Mechanism of silk processing in insects and spiders."
Kim et al., Biomacromolecules, 5:786-792 (2004). "Structure and Properties of Silk Hydrogels."
Kweon et al., J Appl Polymer Sci, 80:1848-1853 (2001). "Preparation of semi-interpenetrating polymer networks composed of silk fibroin and poly(ethylene glycol) macromer. "
Lawrence et al., Biomaterials, 30(7):1299-1308 Author Manuscript (2009). "Silk film biomaterials for cornea tissue engineering."
Lazaris, Science, 295:472-476 (2002). "Spider silk fibers spun from soluble recombinant silk produced in mammalian cells."
Lee et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109:e33-e38 (2010). "A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect."
Leisk et al., Adv. Mater., 22:711-715 (2010). "Electrogelation for Protein Adhesives."
Li et al., Biomaterials, 27:3115-3124 (2006). "Electrospun Silk-BMP-2 scaffolds for bone tissue engineering."
Li et al., J Mater Sci: Mater Med, 19:577-582 (2008). "Effect of silicon on the formation of silk fibroin/calcium phosphate composite."
Liang et al., J Appl Polymer Sci, 45:1937-1943 (1992). "Improvements of the physical properties of fibroin membranes with sodium alginate."
Lin et al., Pharmaceutical Research, 26(3):631-643 (2008). "PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine."
Lowe et al., J Cardiovasc Surg, 48(3):323-331 (2007). "Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized double-blind clinical study."
Lu et al., Acta Biomater. 6(4):1380-1387 (2010). "Water-Insoluble Silk Films with Silk I Structure."
Lu et al., Biomacromolecules, 10:1032-1042 (2009). "Stabilization of Enzymes in Silk Films."
Marcovich et al., Urology, 57:806-810 (2001). "Comparison of 2-Octyl Cyanoacrylate Adhesive, Fibrin Glue, and Suturing for Wound Closure in the Porcine Urinary Tract."
Megeed et al., Pharmaceutical Research, 19(7):954-959 (2002). "Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel."
Monti et al., Journal of Raman Spectroscopy, 29:297-304 (1998). "Raman Spectroscopic Studies of Silk Fibroin from Bombyx mori."
Nazarov et al., Biomacromolecules, 5:718-726 (2004). "Porous 3-D Scaffolds from Regenerated Silk Fibroin."
Pandit et al., Archives of Biochemistry and Biophysics, 149:259-268 (1972). "Studies on Silk Fibroin. I. Molecular Weight, Sedimentation Coefficient, Viscosity and Optical Rotation of Silk Fibroin from Carbonate-Extracted Silk Fiber."
Park et al., Polymer, 45(21):7151-7157 (2004). "Effect of chitosan on morphology and conformation of electrospun silk fibroin nanofibers."
Petrini et al., Journal of Materials Science: Materials in Medicine, 12:849-853 (2001). "Silk fibroin-polyurethane scaffolds for tissue engineering."
Preul et al., J Neurosurg, 107:642-650 (2007). "Application of a hydrogel sealant improves watertight closures of duraplasty onlay grafts in a canine craniotomy model."
Pritchard et al., Exper Opinion on Drug Delivery, 8(6):797-811 (2011). "Silk fibroin biomaterials for controlled release drug delivery."
Pritchard et al., Journal of Controlled Release, 144:159-167 (2010). "Silk fibroin encapsulated powder reservoirs for sustained release of adenosine."
Pritchard et al., Macromol. Biosci., 13:311-320 (2013). "Effect of Silk Protein Processing on Drug Delivery from Silk Films."
Rajkhowa et al., Journal of Applied Polymer Science, 119:1339-1347 (2011). "Molecular Weight and Secondary Structure Change in Eri Silk During Alkali Degumming and Powdering."
Reneker et al., Nanotechnology, 7:216-223 (1996). "Nanometre diameter fibres of polymer, produced by electrospinning."
Samal et al., Macromol. Mater. Eng., DOI: 10.1002/mame.201200377 (2013). "Ultrasound Sonication Effects on Silk Fibroin Protein."
Sawyer et al., JAMA, 191(9):740-742 (1965). "Dextran therapy in thrombophlebitis." Abstract.
Silva et al., Macromol. Biosci., 8:000-000 (2008). "Genipin-Modified Silk Fibroin Nanometric Nets."
Soffer et al., J Biomater Sci Polym Ed., 19(5):653-664 Author Manuscript (2008). "Silk-Based Electrospun Tubular Scaffolds for Tissue Engineered Vascular Grafts."
Sofia et al., Journal of Biomedical Materials Research, 54(1):139-148 (2001). "Functionalized silk-based biomaterials for bone formation."
Spotnitz et al., Transfusion, 48:1502-1516 (2008). "Hemostats, sealants, and adhesives: components of the surgical toolbox."
Torchiana, J Card Surg, 18:504-506 (2003). "Polyethylene Glycol Based Synthetic Sealants: Potential Uses in Cardiac Surgery."
Tsukada et al., J. of Applied Polymer Science, 54(4):507-514 (1994). "Preparation and Application of Porous Silk Fibroin Materials."
U.S. Appl. No. 60/906,509, filed Mar. 13, 2007 by Omenetto et al.
U.S. Appl. No. 61/224,618, filed Jul. 10, 2009 by Numata et al.
Vanderhooft et al., Biomacromolecules, 8:2883-2889 (2007). "Synthesis and Characterization of Novel Thiol-Reactive Poly(ethylene glycol) Cross-Linkers for Extracellular-Matrix-Mimetic Biomaterials."
Wallace et al., J Biomed Mater Res (Appl Biomater), 58:545-555 (2001). "A Tissue Sealant Based on Reactive Multifunctional Polyethylene Glycol."
Wang et al., J Control Release, 134(2):81-90 (2009). "Growth Factor Gradients via Microsphere Delivery in Biopolymer Scaffolds for Osteochondral Tissue Engineering."
Wang et al., Langmuir, 21:11335-11341 (2005). "Biomaterial coatings by stepwise deposition of silk fibroin."
Wenk et al., Diss. Eth No. 18659 (2009). "Silk Fibroin As a Vehicle for Drug Delivery in Tissue Regeneration."
Wheat et al., Urol Clin North Am., 36(2):265-275 (2009). "Advances in Bioadhesives, Tissue Sealants, and Hemostatic Agents."
Wilson et al., PNAS, 98(24):13660-13664 (2001). "Surface organization and nanopatterning of collagen by dip-pen nanolithography."
Wray et al., J Biomed Mater Res Part B, 99B:89-101 (2011). "Effect of Processing on silk based biomaterials: Reproducibility and biocompatibility."
Written Opinion for PCT/US2010/050565, 4 pages (Jun. 29, 2011).
Yamada et al., Materials Science and Engineering C, 14:41-46 (2001). "Preparation of undegraded native molecular fibroin solution from silkworm cocoons."
Yamada et al., Thin Solid Films, 440:208-216 (2003). "AFM observation of silk fibroin on mica substrates: morphologies reflecting the secondary structures."
Yucel et al., J. Struct Biol., 170(2):406-412 (2010). "Non-equilibrium Silk Fibroin Adhesives."
Zhou et al., Chem Commun, 2518-2519 (2001). "Preparation of a novel core-shell nanostructured gold colloid-silk fibroin bioconjugate by the protein in situ redox technique at room temperature."
Zhou et al., Proteins: Structure, Function, and Genetics, 44:119-122 (2001). "Silk Fibroin: Structural Implications of a Remarkable Amino Acid Sequence."

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11192982B2 (en) 2013-09-17 2021-12-07 Bolt Threads, Inc. Methods and compositions for synthesizing improved silk fibers
US11505654B2 (en) 2013-09-17 2022-11-22 Bolt Threads, Inc. Methods and compositions for synthesizing improved silk fibers
US10287728B2 (en) 2014-12-02 2019-05-14 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
US10301768B2 (en) 2014-12-02 2019-05-28 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
US11512425B2 (en) 2015-07-14 2022-11-29 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
US11447532B2 (en) 2016-09-14 2022-09-20 Bolt Threads, Inc. Long uniform recombinant protein fibers
JP2018119252A (en) * 2016-11-16 2018-08-02 アディダス アーゲー Clothing and shoe including spider silk
US11208736B2 (en) 2017-09-25 2021-12-28 Bolt Threads, Inc. Methods of generating highly-crystalline recombinant spider silk protein fibers
US11390988B2 (en) 2017-09-27 2022-07-19 Evolved By Nature, Inc. Silk coated fabrics and products and methods of preparing the same
JP2020537064A (en) * 2017-10-09 2020-12-17 スピベル テクノロジーズ アクティエボラーグ Methods and devices for textile production
WO2020033970A3 (en) * 2018-08-10 2020-03-19 Bolt Threads, Inc. Composition for a molded body

Also Published As

Publication number Publication date
US20120244143A1 (en) 2012-09-27
JP2013506058A (en) 2013-02-21
EP2483460A4 (en) 2013-05-29
CA2775706A1 (en) 2011-03-31
WO2011038401A2 (en) 2011-03-31
EP2483460B1 (en) 2015-09-02
IL218883A0 (en) 2012-06-28
EP2483460A2 (en) 2012-08-08
WO2011038401A3 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
US9074302B2 (en) Methods of making drawn silk fibers
Wang et al. Microfluidic 3D printing responsive scaffolds with biomimetic enrichment channels for bone regeneration
Salehi et al. Spider silk for tissue engineering applications
Heim et al. Spider silk: from soluble protein to extraordinary fiber
Copeland et al. Development of a process for the spinning of synthetic spider silk
Koh et al. Structures, mechanical properties and applications of silk fibroin materials
AU2010307268B2 (en) All-protein implantable, resorbable reflectors
Fan et al. Silk materials for medical, electronic and optical applications
US20140378661A1 (en) Molded regenerated silk geometries using temperature control and mechanical processing
JP6183966B2 (en) Biocomposite and method for producing the same
Zhang et al. Silk fibroin based porous materials
Hsia et al. Spider silk composites and applications
Varkey et al. Impact of silk fibroin-based scaffold structures on human osteoblast MG63 cell attachment and proliferation
Nileback et al. Silk–silk interactions between silkworm fibroin and recombinant spider silk fusion proteins enable the construction of bioactive materials
Radtke Natural occurring silks and their analogues as materials for nerve conduits
Nawrotek et al. Controlling the spatiotemporal release of nerve growth factor by chitosan/polycaprolactone conduits for use in peripheral nerve regeneration
Hohlrieder et al. Bioreactor and scaffold design for the mechanical stimulation of anterior cruciate ligament grafts
US20140296174A1 (en) Silk-based multifunctional biomedical platform
CN109563474A (en) The cell of integration
JP7235248B2 (en) Aligned Porous Fibrous Scaffolds for Tissue Engineering and Surgical Applications
Agapova Silk fibroin and spidroin bioengineering constructions for regenerative medicine and tissue engineering
Allmeling et al. Technical and biomedical uses of nature’s strongest fiber: spider silk
CN110141683A (en) A kind of ligament implant of tough belt supporting frame, its manufacturing process and its composition
Jain Spider silk in medicine
Copeland Production of synthetic spider silk fibers

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRUSTEES OF TUFTS COLLEGE, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LO, TIM JIA-CHING;LEISK, GARY G.;KAPLAN, DAVID L.;REEL/FRAME:025309/0930

Effective date: 20101019

AS Assignment

Owner name: TRUSTEES OF TUFTS COLLEGE, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LO, TIM JIA-CHING;LEISK, GARY G.;KAPLAN, DAVID L.;REEL/FRAME:028135/0803

Effective date: 20101019

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8